US	US	PRP	0
20070003563	20070003563	CD	0
A1	A1	CD	0
20070104	20070104	CD	0
1	1	CD	0
21	21	CD	0
1	1	CD	0
9	9	CD	0
PRT	PRT	NNP	B-NP
Homo	Homo	NNP	I-NP
sapien	sapien	VBD	I-NP
1	1	CD	0
ly	ly	NNP	B-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Ile	Ile	NNP	0
Phe	Phe	NNP	0
Tyr	Tyr	NNP	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
2	2	CD	0
9	9	CD	0
PRT	PRT	NNP	B-NP
Homo	Homo	NNP	I-NP
sapien	sapien	VBD	I-NP
2	2	CD	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
trp	trp	NN	B-NP
ile	ile	NN	I-NP
thr	thr	NN	I-NP
gln	gln	NN	I-NP
cy	cy	NN	I-NP
1	1	CD	0
5	5	CD	0
3	3	CD	0
9	9	CD	0
PRT	PRT	NNP	B-NP
Homo	Homo	NNP	I-NP
sapien	sapien	VBD	I-NP
3	3	CD	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
1	1	CD	0
5	5	CD	0
4	4	CD	0
10	10	CD	0
PRT	PRT	NNP	B-NP
Homo	Homo	NNP	I-NP
sapien	sapien	VBD	I-NP
4	4	CD	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Pro	Pro	FW	0
Val	Val	FW	0
His	His	FW	0
Pro	Pro	NN	B-NP
Ile	Ile	NNP	I-NP
1	1	CD	0
5	5	CD	0
10	10	CD	0
5	5	CD	0
9	9	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
5	5	CD	0
ly	ly	NNP	B-NP
Val	Val	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Ile	Ile	NNP	0
Phe	Phe	NNP	0
Tyr	Tyr	NNP	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
6	6	CD	0
9	9	CD	0
ny-eso-1	ny-eso-1	NN	B-NP
prt	prt	NN	I-NP
artificial	artificial	JJ	I-NP
sequence	sequence	NN	I-NP
analog	analog	NN	I-NP
,	,	,	0
amino	amino	FW	0
acids	acids	FW	0
157-165	157-165	FW	0
VARIANT	VARIANT	NNP	0
2	2	CD	0
Xaa	Xaa	NNP	B-NP
=	=	NNP	0
Norvaline	Norvaline	NNP	B-NP
6	6	CD	0
Ser	Ser	NNP	0
Xaa	Xaa	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
Trp	Trp	NNP	0
Ile	Ile	NNP	0
Thr	Thr	NNP	0
Gln	Gln	NNP	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
7	7	CD	0
9	9	CD	0
prame	prame	NN	B-NP
prt	prt	NN	I-NP
artificial	artificial	JJ	I-NP
sequence	sequence	NN	I-NP
analog	analog	NN	I-NP
,	,	,	0
amino	amino	FW	0
acids	acids	FW	0
425-433	425-433	FW	0
VARIANT	VARIANT	NNP	0
2	2	CD	0
Xaa	Xaa	NNP	B-NP
=	=	NNP	0
Norvaline	Norvaline	NNP	B-NP
VARIANT	VARIANT	NNP	I-NP
9	9	CD	0
Xaa	Xaa	NNP	B-NP
=	=	NNP	0
Norleucine	Norleucine	NNP	B-NP
7	7	CD	0
Ser	Ser	NNP	0
Xaa	Xaa	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	B-NP
Ile	Ile	NNP	I-NP
Gly	Gly	NNP	I-NP
Xaa	Xaa	NNP	I-NP
1	1	CD	0
5	5	CD	0
8	8	CD	0
10	10	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
8	8	CD	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Pro	Pro	FW	0
Val	Val	FW	0
His	His	FW	0
Pro	Pro	FW	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
10	10	CD	0
9	9	CD	0
10	10	CD	0
PRT	PRT	NNP	B-NP
Homo	Homo	NNP	I-NP
sapien	sapien	VBD	I-NP
9	9	CD	0
Glu	Glu	NNP	0
Leu	Leu	NNP	0
Ala	Ala	NNP	0
Gly	Gly	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Ile	Ile	NNP	0
Leu	Leu	NNP	0
Thr	Thr	NNP	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
10	10	CD	0
10	10	CD	0
9	9	CD	0
PRT	PRT	NNP	B-NP
Homo	Homo	NNP	I-NP
sapien	sapien	VBD	I-NP
10	10	CD	0
Tyr	Tyr	NNP	B-NP
Met	Met	NNP	0
Asp	Asp	NNP	B-NP
Gly	Gly	NNP	I-NP
Thr	Thr	NNP	I-NP
Met	Met	NNP	0
Ser	Ser	NNP	0
Gln	Gln	NNP	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
11	11	CD	0
10	10	CD	0
melan-a	melan-a	NN	B-NP
prt	prt	NN	I-NP
artificial	artificial	JJ	I-NP
sequence	sequence	NN	I-NP
analog	analog	NN	I-NP
,	,	,	0
amino	amino	FW	0
acids	acids	FW	0
26-35	26-35	FW	0
VARIANT	VARIANT	NNP	0
2	2	CD	0
Xaa	Xaa	NNP	B-NP
=	=	NNP	0
Norvaline	Norvaline	NNP	B-NP
11	11	NNP	0
Glu	Glu	NNP	0
Xaa	Xaa	NNP	0
Ala	Ala	NNP	0
Gly	Gly	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Ile	Ile	NNP	0
Leu	Leu	NNP	0
Thr	Thr	NNP	0
Val	Val	NNP	0
1	1	CD	0
5	5	CD	0
10	10	CD	0
12	12	CD	0
9	9	CD	0
tyrosinase	tyrosinase	NN	B-NP
prt	prt	NN	I-NP
artificial	artificial	JJ	I-NP
sequence	sequence	NN	I-NP
analog	analog	NN	I-NP
,	,	,	0
amino	amino	FW	0
acids	acids	FW	0
369-377	369-377	FW	0
VARIANT	VARIANT	NNP	0
9	9	CD	0
Xaa	Xaa	NNP	B-NP
=	=	NNP	0
Norvaline	Norvaline	NNP	B-NP
12	12	CD	0
Tyr	Tyr	NNP	B-NP
Met	Met	NNP	0
Asp	Asp	NNP	B-NP
Gly	Gly	NNP	I-NP
Thr	Thr	NNP	I-NP
Met	Met	NNP	0
Ser	Ser	NNP	0
Gln	Gln	NNP	0
Xaa	Xaa	NNP	0
1	1	CD	0
5	5	CD	0
13	13	CD	0
29	29	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
13	13	CD	0
ile	ile	NN	B-NP
ly	ly	NNP	I-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Ile	Ile	NNP	0
Phe	Phe	NNP	0
Tyr	Tyr	NNP	0
Val	Val	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
Trp	Trp	NNP	B-NP
Ile	Ile	NNP	I-NP
1	1	CD	0
5	5	CD	0
10	10	CD	0
15	15	CD	0
ly	ly	NNP	B-NP
thr	thr	NN	I-NP
gln	gln	NN	I-NP
cy	cy	NN	I-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
ile	ile	NN	B-NP
phe	phe	NN	I-NP
tyr	tyr	NN	I-NP
val	val	NNP	I-NP
ly	ly	NNP	I-NP
20	20	CD	0
25	25	CD	0
14	14	CD	0
62	62	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
14	14	CD	0
ly	ly	NNP	B-NP
Arg	Arg	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	B-NP
Ile	Ile	NNP	I-NP
Gly	Gly	NNP	I-NP
Leu	Leu	NNP	I-NP
Gly	Gly	NNP	I-NP
Asp	Asp	NNP	I-NP
Ala	Ala	NNP	I-NP
Ala	Ala	NNP	I-NP
Tyr	Tyr	NNP	I-NP
1	1	CD	0
5	5	CD	0
10	10	CD	0
15	15	CD	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Ser	Ser	NNP	0
Pro	Pro	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Glu	Glu	NNP	B-NP
Glu	Glu	NNP	I-NP
20	20	CD	0
25	25	CD	0
30	30	CD	0
Gln	Gln	NNP	0
Tyr	Tyr	NNP	0
Ile	Ile	NNP	0
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
arg	arg	NN	B-NP
pro	pro	NN	I-NP
leu	leu	NNP	I-NP
ile	ile	NN	I-NP
gly	gly	NN	I-NP
leu	leu	NNP	I-NP
ly	ly	NNP	I-NP
35	35	CD	0
40	40	CD	0
45	45	CD	0
Ser	Ser	NNP	0
Ile	Ile	NNP	0
Lys	Lys	NNP	0
Arg	Arg	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Pro	Pro	FW	0
Val	Val	FW	0
His	His	FW	0
Pro	Pro	FW	0
Val	Val	NNP	0
50	50	CD	0
55	55	CD	0
60	60	CD	0
15	15	CD	0
28	28	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
15	15	CD	0
Met	Met	NNP	0
leu	leu	NNP	B-NP
glu	glu	NN	I-NP
leu	leu	NNP	I-NP
ala	ala	NNP	I-NP
gly	gly	NN	I-NP
ile	ile	NN	I-NP
gly	gly	NN	I-NP
ile	ile	NN	I-NP
leu	leu	NNP	I-NP
leu	leu	NNP	I-NP
ala	ala	NNP	I-NP
val	val	NNP	I-NP
leu	leu	NNP	I-NP
tyr	tyr	NN	I-NP
cy	cy	NN	I-NP
1	1	CD	0
5	5	CD	0
10	10	CD	0
15	15	CD	0
Leu	Leu	NNP	B-NP
Thr	Thr	NNP	I-NP
Val	Val	NNP	I-NP
Tyr	Tyr	NNP	I-NP
Met	Met	NNP	0
Asp	Asp	NNP	B-NP
Gly	Gly	NNP	I-NP
Thr	Thr	NNP	I-NP
Met	Met	NNP	0
Ser	Ser	NNP	0
Gln	Gln	NNP	0
Val	Val	NNP	0
20	20	CD	0
25	25	CD	0
16	16	CD	0
179	179	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
16	16	CD	0
Met	Met	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
ly	ly	NNP	B-NP
trp	trp	NN	I-NP
ile	ile	NN	I-NP
thr	thr	NN	I-NP
gln	gln	NN	I-NP
cy	cy	NN	I-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Ile	Ile	NNP	B-NP
1	1	CD	0
5	5	CD	0
10	10	CD	0
15	15	CD	0
Phe	Phe	NNP	0
Tyr	Tyr	NNP	0
Val	Val	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Pro	Pro	FW	0
Val	Val	FW	0
His	His	FW	0
Pro	Pro	NN	B-NP
Ile	Ile	NNP	I-NP
Gly	Gly	NNP	I-NP
Leu	Leu	NNP	I-NP
Pro	Pro	NNP	I-NP
20	20	CD	0
25	25	CD	0
30	30	CD	0
Ser	Ser	NNP	0
Ile	Ile	NNP	0
Pro	Pro	FW	0
Val	Val	FW	0
His	His	FW	0
pro	pro	NN	B-NP
ile	ile	NN	I-NP
ly	ly	NNP	I-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Ile	Ile	NNP	0
Phe	Phe	NNP	0
Tyr	Tyr	NNP	0
Val	Val	NNP	0
35	35	CD	0
40	40	CD	0
45	45	CD	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
ly	ly	NNP	B-NP
trp	trp	NN	I-NP
ile	ile	NN	I-NP
thr	thr	NN	I-NP
gln	gln	NN	I-NP
cy	cy	NN	I-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
Ile	Ile	NNP	B-NP
Phe	Phe	NNP	I-NP
50	50	CD	0
55	55	CD	0
60	60	CD	0
tyr	tyr	NN	B-NP
val	val	NNP	I-NP
ly	ly	NNP	I-NP
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
gly	gly	NN	B-NP
ala	ala	NNP	I-NP
arg	arg	NN	I-NP
ile	ile	NN	I-NP
phe	phe	NN	I-NP
tyr	tyr	NN	I-NP
val	val	NNP	I-NP
arg	arg	NN	I-NP
cy	cy	NN	I-NP
65	65	CD	0
70	70	CD	0
75	75	CD	0
80	80	CD	0
Gly	Gly	NNP	0
Pro	Pro	NNP	0
Glu	Glu	NNP	0
Ser	Ser	NNP	0
Arg	Arg	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Glu	Glu	NNP	0
Phe	Phe	NNP	0
Tyr	Tyr	NNP	0
Leu	Leu	NNP	0
Ala	Ala	NNP	0
Met	Met	NNP	0
Pro	Pro	NNP	0
Phe	Phe	NNP	0
Ala	Ala	NNP	0
85	85	CD	0
90	90	CD	0
95	95	CD	0
Thr	Thr	NNP	B-NP
Pro	Pro	NNP	I-NP
Met	Met	NNP	0
Glu	Glu	NNP	0
Ala	Ala	NNP	0
Glu	Glu	NNP	0
Leu	Leu	NNP	0
Ala	Ala	NNP	0
Arg	Arg	NNP	0
Arg	Arg	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Ala	Ala	NNP	0
Gln	Gln	NNP	0
Asp	Asp	NNP	0
Ala	Ala	NNP	0
100	100	CD	0
105	105	CD	0
110	110	CD	0
pro	pro	NN	B-NP
pro	pro	NN	I-NP
leu	leu	NNP	I-NP
pro	pro	NN	I-NP
val	val	NNP	I-NP
pro	pro	NN	I-NP
gly	gly	NN	I-NP
val	val	NNP	I-NP
leu	leu	NNP	I-NP
leu	leu	NNP	I-NP
ly	ly	NNP	I-NP
Glu	Glu	NNP	0
Phe	Phe	NNP	0
Thr	Thr	NNP	0
Val	Val	NNP	0
Ser	Ser	NNP	0
115	115	CD	0
120	120	CD	0
125	125	CD	0
Gly	Gly	NNP	B-NP
Asn	Asn	NNP	I-NP
Ile	Ile	NNP	I-NP
Leu	Leu	NNP	I-NP
Thr	Thr	NNP	I-NP
Ile	Ile	NNP	I-NP
Arg	Arg	NNP	I-NP
Leu	Leu	NNP	I-NP
Thr	Thr	NNP	I-NP
Ala	Ala	NNP	I-NP
Ala	Ala	NNP	I-NP
Asp	Asp	NNP	I-NP
His	His	NNP	0
Arg	Arg	NNP	0
Gln	Gln	NNP	0
Leu	Leu	NNP	0
130	130	CD	0
135	135	CD	0
140	140	CD	0
Gln	Gln	NNP	0
Leu	Leu	NNP	0
Ser	Ser	NNP	0
Ile	Ile	NNP	0
Ser	Ser	NNP	0
Ser	Ser	NNP	0
Cys	Cys	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
Gln	Gln	NNP	0
Leu	Leu	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
Trp	Trp	NNP	B-NP
145	145	CD	0
150	150	CD	0
155	155	CD	0
160	160	CD	0
ile	ile	NN	B-NP
thr	thr	NN	I-NP
gln	gln	NN	I-NP
cy	cy	NN	I-NP
Phe	Phe	NNP	0
Leu	Leu	NNP	0
Pro	Pro	FW	0
Val	Val	FW	0
Phe	Phe	FW	0
Leu	Leu	FW	0
Ala	Ala	FW	0
Gln	Gln	FW	0
Pro	Pro	FW	0
Pro	Pro	FW	0
Ser	Ser	NNP	0
Gly	Gly	NNP	0
165	165	CD	0
170	170	CD	0
175	175	CD	0
Gln	Gln	NNP	B-NP
Arg	Arg	NNP	I-NP
Arg	Arg	NNP	I-NP
17	17	CD	0
275	275	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
17	17	CD	0
Met	Met	NNP	0
Asn	Asn	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
His	His	NNP	0
Glu	Glu	NNP	0
Thr	Thr	NNP	0
Asp	Asp	NNP	0
Ser	Ser	NNP	0
Ala	Ala	NNP	0
Val	Val	NNP	0
Ala	Ala	NNP	0
Thr	Thr	NNP	0
Ala	Ala	NNP	0
Arg	Arg	NNP	0
Arg	Arg	NNP	0
1	1	CD	0
5	5	CD	0
10	10	CD	0
15	15	CD	0
ala	ala	NNP	B-NP
gly	gly	NN	I-NP
ala	ala	NNP	I-NP
leu	leu	NNP	I-NP
val	val	NNP	I-NP
leu	leu	NNP	I-NP
ala	ala	NNP	I-NP
gly	gly	NN	I-NP
gly	gly	NN	I-NP
phe	phe	NN	I-NP
phe	phe	NN	I-NP
pro	pro	NN	I-NP
arg	arg	NN	I-NP
trp	trp	NN	I-NP
leu	leu	NNP	I-NP
cy	cy	NN	I-NP
20	20	CD	0
25	25	CD	0
30	30	CD	0
leu	leu	NNP	B-NP
leu	leu	NNP	I-NP
gly	gly	NN	I-NP
phe	phe	NN	I-NP
leu	leu	NNP	I-NP
phe	phe	NN	I-NP
gly	gly	NN	I-NP
trp	trp	NN	I-NP
phe	phe	NN	I-NP
ile	ile	NN	I-NP
ly	ly	NNP	I-NP
Ser	Ser	NNP	0
Ala	Ala	NNP	0
Gln	Gln	NNP	0
Leu	Leu	NNP	0
Ala	Ala	NNP	0
35	35	CD	0
40	40	CD	0
45	45	CD	0
gly	gly	NN	B-NP
ala	ala	NNP	I-NP
ly	ly	NNP	I-NP
Gly	Gly	NNP	0
Val	Val	NNP	0
Ile	Ile	NNP	0
Leu	Leu	NNP	0
Tyr	Tyr	NNP	0
Ser	Ser	NNP	0
Asp	Asp	NNP	0
Pro	Pro	NNP	0
Ala	Ala	NNP	0
Asp	Asp	NNP	0
Tyr	Tyr	NNP	0
Phe	Phe	NNP	0
Ala	Ala	NNP	0
50	50	CD	0
55	55	CD	0
60	60	CD	0
pro	pro	NN	B-NP
gly	gly	NN	I-NP
val	val	NNP	I-NP
ly	ly	NNP	I-NP
Ser	Ser	FW	0
Tyr	Tyr	FW	0
Pro	Pro	FW	0
Asp	Asp	FW	0
Gly	Gly	FW	0
Trp	Trp	FW	0
Asn	Asn	FW	0
Leu	Leu	FW	0
Pro	Pro	FW	0
Gly	Gly	NNP	0
Gly	Gly	NNP	0
Gly	Gly	NNP	0
65	65	CD	0
70	70	CD	0
75	75	CD	0
80	80	CD	0
Val	Val	NNP	0
Gln	Gln	NNP	0
Arg	Arg	NNP	0
Gly	Gly	NNP	0
Asn	Asn	NNP	0
Ile	Ile	NNP	0
Leu	Leu	NNP	0
Asn	Asn	NNP	0
Leu	Leu	NNP	0
Asn	Asn	NNP	0
Gly	Gly	NNP	0
Ala	Ala	NNP	0
Gly	Gly	NNP	0
Asp	Asp	NNP	0
Pro	Pro	NNP	0
Leu	Leu	NNP	0
85	85	CD	0
90	90	CD	0
95	95	CD	0
Thr	Thr	FW	0
Pro	Pro	FW	0
Gly	Gly	FW	0
Tyr	Tyr	FW	0
Pro	Pro	FW	0
Ala	Ala	NNP	0
Asn	Asn	NNP	0
Glu	Glu	NNP	0
Tyr	Tyr	NNP	0
Ala	Ala	NNP	0
Tyr	Tyr	NNP	0
Arg	Arg	NNP	0
Arg	Arg	NNP	0
Gly	Gly	NNP	0
Ile	Ile	NNP	0
Ala	Ala	NNP	0
100	100	CD	0
105	105	CD	0
110	110	CD	0
Glu	Glu	NNP	0
Ala	Ala	NNP	0
Val	Val	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Pro	Pro	FW	0
Val	Val	FW	0
His	His	FW	0
Pro	Pro	NN	B-NP
Ile	Ile	NNP	I-NP
Ala	Ala	NNP	I-NP
Leu	Leu	NNP	I-NP
Gln	Gln	NNP	I-NP
115	115	CD	0
120	120	CD	0
125	125	CD	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Ser	Ser	NNP	0
Asn	Asn	NNP	0
Leu	Leu	NNP	0
Thr	Thr	NNP	0
His	His	NNP	0
Val	Val	NNP	0
Leu	Leu	NNP	0
130	130	CD	0
135	135	CD	0
140	140	CD	0
Tyr	Tyr	FW	0
Pro	Pro	FW	0
Val	Val	FW	0
Pro	Pro	FW	0
Leu	Leu	NNP	0
Glu	Glu	NNP	0
Ser	Ser	NNP	0
Tyr	Tyr	NNP	0
Glu	Glu	NNP	0
Asp	Asp	NNP	0
Ile	Ile	NNP	0
His	His	NNP	0
Gly	Gly	NNP	0
Thr	Thr	NNP	0
Leu	Leu	NNP	0
His	His	NNP	0
145	145	CD	0
150	150	CD	0
155	155	CD	0
160	160	CD	0
Leu	Leu	NNP	0
Glu	Glu	NNP	0
Arg	Arg	NNP	0
Leu	Leu	NNP	0
Ala	Ala	NNP	0
Tyr	Tyr	NNP	0
Leu	Leu	NNP	0
His	His	NNP	0
ala	ala	NNP	B-NP
arg	arg	NN	I-NP
leu	leu	NNP	I-NP
arg	arg	NN	I-NP
glu	glu	NN	I-NP
leu	leu	NNP	I-NP
leu	leu	NNP	I-NP
cy	cy	NN	I-NP
165	165	CD	0
170	170	CD	0
175	175	CD	0
Glu	Glu	NNP	0
Leu	Leu	NNP	0
Gly	Gly	NNP	0
Arg	Arg	NNP	0
Pro	Pro	NNP	0
Ser	Ser	NNP	0
Met	Met	NNP	0
Val	Val	NNP	0
Trp	Trp	NNP	0
Leu	Leu	NNP	0
Ser	Ser	NNP	0
Ala	Ala	NNP	0
Asn	Asn	NNP	0
Pro	Pro	NNP	0
Cys	Cys	NNP	0
Pro	Pro	NNP	0
180	180	CD	0
185	185	CD	0
190	190	CD	0
His	His	PRP$	0
gly	gly	NN	B-NP
asp	asp	NN	I-NP
arg	arg	NN	I-NP
thr	thr	NN	I-NP
phe	phe	NN	I-NP
tyr	tyr	NN	I-NP
asp	asp	NN	I-NP
pro	pro	NN	I-NP
glu	glu	NN	I-NP
pro	pro	NN	I-NP
ile	ile	NN	I-NP
leu	leu	NNP	I-NP
cy	cy	NN	I-NP
cy	cy	NN	I-NP
Pro	Pro	NNP	0
195	195	CD	0
200	200	CD	0
205	205	CD	0
phe	phe	NN	B-NP
cy	cy	NN	I-NP
Met	Met	NNP	0
pro	pro	NN	B-NP
asn	asn	NN	I-NP
ly	ly	NNP	I-NP
Arg	Arg	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
210	210	CD	0
215	215	CD	0
220	220	CD	0
Gly	Gly	NNP	0
Asp	Asp	NNP	0
Ala	Ala	NNP	0
Ala	Ala	NNP	0
Tyr	Tyr	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Gly	Gly	NNP	0
Leu	Leu	NNP	0
Ile	Ile	NNP	0
Ser	Ser	NNP	0
225	225	CD	0
230	230	CD	0
235	235	CD	0
240	240	CD	0
pro	pro	NN	B-NP
glu	glu	NN	I-NP
ly	ly	NNP	I-NP
Glu	Glu	NNP	0
Glu	Glu	NNP	0
Gln	Gln	NNP	0
Tyr	Tyr	NNP	0
Ile	Ile	NNP	0
Ala	Ala	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
His	His	NNP	0
Leu	Leu	NNP	B-NP
Ile	Ile	NNP	I-NP
245	245	CD	0
250	250	CD	0
255	255	CD	0
gly	gly	NN	B-NP
leu	leu	NNP	I-NP
ly	ly	NNP	I-NP
Arg	Arg	NNP	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Lys	Lys	FW	0
Arg	Arg	FW	0
Gly	Gly	FW	0
Leu	Leu	FW	0
Pro	Pro	FW	0
Ser	Ser	FW	0
Ile	Ile	FW	0
Pro	Pro	FW	0
Val	Val	NNP	0
260	260	CD	0
265	265	CD	0
270	270	CD	0
His	His	PRP$	0
Pro	Pro	FW	0
Val	Val	NNP	0
275	275	CD	0
18	18	CD	0
94	94	CD	0
PRT	PRT	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Man	Man	NNP	I-NP
made	made	VBD	0
peptide	peptide	CD	B-NP
18	18	CD	0
Met	Met	NNP	0
leu	leu	NNP	B-NP
glu	glu	NN	I-NP
leu	leu	NNP	I-NP
ala	ala	NNP	I-NP
gly	gly	NN	I-NP
ile	ile	NN	I-NP
gly	gly	NN	I-NP
ile	ile	NN	I-NP
leu	leu	NNP	I-NP
leu	leu	NNP	I-NP
ala	ala	NNP	I-NP
val	val	NNP	I-NP
leu	leu	NNP	I-NP
tyr	tyr	NN	I-NP
cy	cy	NN	I-NP
1	1	CD	0
5	5	CD	0
10	10	CD	0
15	15	CD	0
Leu	Leu	NNP	B-NP
Thr	Thr	NNP	I-NP
Val	Val	NNP	I-NP
Tyr	Tyr	NNP	I-NP
Met	Met	NNP	0
Asp	Asp	NNP	B-NP
Gly	Gly	NNP	I-NP
Thr	Thr	NNP	I-NP
Met	Met	NNP	0
Ser	Ser	NNP	0
Gln	Gln	NNP	0
Val	Val	NNP	0
Gly	Gly	NNP	0
Ile	Ile	NNP	0
Leu	Leu	NNP	0
Thr	Thr	NNP	0
20	20	CD	0
25	25	CD	0
30	30	CD	0
trp	trp	NN	B-NP
tyr	tyr	NN	I-NP
cy	cy	NN	I-NP
val	val	NNP	I-NP
ile	ile	NN	I-NP
leu	leu	NNP	I-NP
gly	gly	NN	I-NP
val	val	NNP	I-NP
leu	leu	NNP	I-NP
leu	leu	NNP	I-NP
leu	leu	NNP	I-NP
ile	ile	NN	I-NP
gly	gly	NN	I-NP
cy	cy	NN	I-NP
Arg	Arg	NNP	B-NP
Arg	Arg	NNP	I-NP
35	35	CD	0
40	40	CD	0
45	45	CD	0
Arg	Arg	NNP	0
Asn	Asn	NNP	0
Gly	Gly	NNP	0
Tyr	Tyr	NNP	0
Arg	Arg	NNP	0
Ala	Ala	NNP	0
Leu	Leu	NNP	0
Met	Met	NNP	0
asp	asp	NN	B-NP
ly	ly	NNP	I-NP
Ser	Ser	NNP	0
Leu	Leu	NNP	0
His	His	NNP	0
Val	Val	NNP	B-NP
Gly	Gly	NNP	I-NP
Thr	Thr	NNP	I-NP
50	50	CD	0
55	55	CD	0
60	60	CD	0
ala	ala	NNP	B-NP
leu	leu	NNP	I-NP
thr	thr	NN	I-NP
arg	arg	NN	I-NP
arg	arg	NN	I-NP
cy	cy	NN	I-NP
gln	gln	NN	I-NP
cy	cy	NN	I-NP
Pro	Pro	NNP	B-NP
Gln	Gln	NNP	I-NP
Glu	Glu	NNP	I-NP
Gly	Gly	NNP	I-NP
Phe	Phe	NNP	I-NP
Asp	Asp	NNP	I-NP
His	His	NNP	0
Arg	Arg	NNP	B-NP
65	65	CD	0
70	70	CD	0
75	75	CD	0
80	80	CD	0
Asp	Asp	NNP	0
Ser	Ser	NNP	0
Lys	Lys	NNP	0
Val	Val	NNP	0
Ser	Ser	NNP	0
Leu	Leu	NNP	0
Gln	Gln	NNP	0
Glu	Glu	NNP	0
Lys	Lys	NNP	0
asn	asn	NN	B-NP
cy	cy	NN	I-NP
Glu	Glu	NNP	0
Pro	Pro	NNP	0
Val	Val	NNP	0
85	85	CD	0
90	90	CD	0
19	19	CD	0
3315	3315	CD	0
DNA	DNA	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Plasmid	Plasmid	NNP	I-NP
19	19	CD	0
atatacgcgt	atatacgcgt	NN	B-NP
tgacattgat	tgacattgat	NN	B-NP
tattgactag	tattgactag	NN	B-NP
ttattaatag	ttattaatag	NN	B-NP
taatcaatta	taatcaatta	NN	B-NP
cggggtcatt	cggggtcatt	NN	B-NP
60	60	NNP	0
agttcatagc	agttcatagc	NN	B-NP
ccatatatgg	ccatatatgg	NN	B-NP
agttccgcgt	agttccgcgt	NN	B-NP
tacataactt	tacataactt	NN	B-NP
acggtaaatg	acggtaaatg	NN	B-NP
gcccgcctgg	gcccgcctgg	NN	B-NP
120	120	FW	0
ctgaccgccc	ctgaccgccc	NN	B-NP
aacgaccccc	aacgaccccc	NN	B-NP
gcccattgac	gcccattgac	NN	B-NP
gtcaataatg	gtcaataatg	NN	B-NP
acgtatgttc	acgtatgttc	NN	B-NP
ccatagtaac	ccatagtaac	NN	B-NP
180	180	FW	0
gccaataggg	gccaataggg	NN	B-NP
actttccatt	actttccatt	NN	B-NP
gacgtcaatg	gacgtcaatg	NN	B-NP
ggtggagtat	ggtggagtat	NN	B-NP
ttacggtaaa	ttacggtaaa	NN	B-NP
ctgcccactt	ctgcccactt	NN	B-NP
240	240	FW	0
ggcagtacat	ggcagtacat	NN	B-NP
caagtgtatc	caagtgtatc	NN	B-NP
atatgccaag	atatgccaag	NN	B-NP
tacgccccct	tacgccccct	NN	B-NP
attgacgtca	attgacgtca	NN	B-NP
atgacggtaa	atgacggtaa	NN	B-NP
300	300	FW	0
atggcccgcc	atggcccgcc	NN	B-NP
tggcattatg	tggcattatg	NN	B-NP
cccagtacat	cccagtacat	NN	B-NP
gaccttatgg	gaccttatgg	NN	B-NP
gactttccta	gactttccta	NN	B-NP
cttggcagta	cttggcagta	NN	B-NP
360	360	FW	0
catctacgta	catctacgta	NN	B-NP
ttagtcatcg	ttagtcatcg	NN	B-NP
ctattaccat	ctattaccat	NN	B-NP
ggtgatgcgg	ggtgatgcgg	NN	B-NP
ttttggcagt	ttttggcagt	NN	B-NP
acatcaatgg	acatcaatgg	NN	B-NP
420	420	FW	0
gcgtggatag	gcgtggatag	NN	B-NP
cggtttgact	cggtttgact	NN	B-NP
cacggggatt	cacggggatt	NN	B-NP
tccaagtctc	tccaagtctc	NN	B-NP
caccccattg	caccccattg	NN	B-NP
acgtcaatgg	acgtcaatgg	NN	B-NP
480	480	FW	0
gagtttgttt	gagtttgttt	NN	B-NP
tggcaccaaa	tggcaccaaa	NN	B-NP
atcaacggga	atcaacggga	NN	B-NP
ctttccaaaa	ctttccaaaa	NN	B-NP
tgtcgtaaca	tgtcgtaaca	NN	B-NP
actccgcccc	actccgcccc	NN	B-NP
540	540	FW	0
attgacgcaa	attgacgcaa	NN	B-NP
atgggcggta	atgggcggta	NN	B-NP
ggcgtgtacg	ggcgtgtacg	NN	B-NP
gtgggaggtc	gtgggaggtc	NN	B-NP
tatataagca	tatataagca	NN	B-NP
gagctctctg	gagctctctg	NN	B-NP
600	600	FW	0
gctaactaga	gctaactaga	NN	B-NP
gaacccactg	gaacccactg	NN	B-NP
cttactggct	cttactggct	NN	B-NP
tatcgaaatt	tatcgaaatt	NN	B-NP
aatacgactc	aatacgactc	NN	B-NP
actataggga	actataggga	NN	B-NP
660	660	FW	0
gacccaagct	gacccaagct	NN	B-NP
ggctagcgtt	ggctagcgtt	NN	B-NP
taaacttaag	taaacttaag	NN	B-NP
ccaccatgtt	ccaccatgtt	NN	B-NP
actagctgtt	actagctgtt	NN	B-NP
ttgtactgcc	ttgtactgcc	NN	B-NP
720	720	FW	0
tggaactagc	tggaactagc	NN	B-NP
agggatcggc	agggatcggc	NN	B-NP
atattgacag	atattgacag	NN	B-NP
tgtatatgga	tgtatatgga	NN	B-NP
tggaacaatg	tggaacaatg	NN	B-NP
tcccaggtag	tcccaggtag	NN	B-NP
780	780	FW	0
gaattctgac	gaattctgac	NN	B-NP
agtgatcctg	agtgatcctg	NN	B-NP
ggagtcttac	ggagtcttac	NN	B-NP
tgctcatcgg	tgctcatcgg	NN	B-NP
ctgttggtat	ctgttggtat	NN	B-NP
tgtagaagac	tgtagaagac	NN	B-NP
840	840	FW	0
gaaatggata	gaaatggata	NN	B-NP
cagagccttg	cagagccttg	NN	B-NP
atggataaaa	atggataaaa	NN	B-NP
gtcttcatgt	gtcttcatgt	NN	B-NP
tggcactcaa	tggcactcaa	NN	B-NP
tgtgccttaa	tgtgccttaa	NN	B-NP
900	900	FW	0
caagaagatg	caagaagatg	NN	B-NP
cccacaagaa	cccacaagaa	NN	B-NP
gggtttgatc	gggtttgatc	NN	B-NP
atcgggacag	atcgggacag	NN	B-NP
caaagtgtct	caaagtgtct	NN	B-NP
cttcaagaga	cttcaagaga	NN	B-NP
960	960	FW	0
aaaactgtga	aaaactgtga	NN	B-NP
acctgtgtag	acctgtgtag	NN	B-NP
tgagcggccg	tgagcggccg	NN	B-NP
ctcgagtcta	ctcgagtcta	NN	B-NP
gagggcccgt	gagggcccgt	NN	B-NP
ttaaacccgc	ttaaacccgc	NN	B-NP
1020	1020	FW	0
tgatcagcct	tgatcagcct	NN	B-NP
cgactgtgcc	cgactgtgcc	NN	B-NP
ttctagttgc	ttctagttgc	NN	B-NP
cagccatctg	cagccatctg	NN	B-NP
ttgtttgccc	ttgtttgccc	NN	B-NP
ctcccccgtg	ctcccccgtg	NN	B-NP
1080	1080	FW	0
ccttccttga	ccttccttga	NN	B-NP
ccctggaagg	ccctggaagg	NN	B-NP
tgccactccc	tgccactccc	NN	B-NP
actgtccttt	actgtccttt	NN	B-NP
cctaataaaa	cctaataaaa	NN	B-NP
tgaggaaatt	tgaggaaatt	NN	B-NP
1140	1140	FW	0
gcatcgcatt	gcatcgcatt	NN	B-NP
gtctgagtag	gtctgagtag	NN	B-NP
gtgtcattct	gtgtcattct	NN	B-NP
attctggggg	attctggggg	NN	B-NP
gtggggtggg	gtggggtggg	NN	B-NP
gcaggacagc	gcaggacagc	NN	B-NP
1200	1200	FW	0
aagggggagg	aagggggagg	NN	B-NP
attgggaaga	attgggaaga	NN	B-NP
caatagcagg	caatagcagg	NN	B-NP
catgctgggg	catgctgggg	NN	B-NP
atgcggtggg	atgcggtggg	NN	B-NP
ctctatggct	ctctatggct	NN	B-NP
1260	1260	FW	0
tctactgggc	tctactgggc	NN	B-NP
ggttttatgg	ggttttatgg	NN	B-NP
acagcaagcg	acagcaagcg	NN	B-NP
aaccggaatt	aaccggaatt	NN	B-NP
gccagctggg	gccagctggg	NN	B-NP
gcgccctctg	gcgccctctg	NN	B-NP
1320	1320	FW	0
gtaaggttgg	gtaaggttgg	NN	B-NP
gaagccctgc	gaagccctgc	NN	B-NP
aaagtaaact	aaagtaaact	NN	B-NP
ggatggcttt	ggatggcttt	NN	B-NP
cttgccgcca	cttgccgcca	NN	B-NP
aggatctgat	aggatctgat	NN	B-NP
1380	1380	FW	0
ggcgcagggg	ggcgcagggg	NN	B-NP
atcaagctct	atcaagctct	NN	B-NP
gatcaagaga	gatcaagaga	NN	B-NP
caggatgagg	caggatgagg	NN	B-NP
atcgtttcgc	atcgtttcgc	NN	B-NP
atgattgaac	atgattgaac	NN	B-NP
1440	1440	FW	0
aagatggatt	aagatggatt	NN	B-NP
gcacgcaggt	gcacgcaggt	NN	B-NP
tctccggccg	tctccggccg	NN	B-NP
cttgggtgga	cttgggtgga	NN	B-NP
gaggctattc	gaggctattc	NN	B-NP
ggctatgact	ggctatgact	NN	B-NP
1500	1500	FW	0
gggcacaaca	gggcacaaca	NN	B-NP
gacaatcggc	gacaatcggc	NN	B-NP
tgctctgatg	tgctctgatg	NN	B-NP
ccgccgtgtt	ccgccgtgtt	NN	B-NP
ccggctgtca	ccggctgtca	NN	B-NP
gcgcaggggc	gcgcaggggc	NN	B-NP
1560	1560	FW	0
gcccggttct	gcccggttct	NN	B-NP
ttttgtcaag	ttttgtcaag	NN	B-NP
accgacctgt	accgacctgt	NN	B-NP
ccggtgccct	ccggtgccct	NN	B-NP
gaatgaactg	gaatgaactg	NN	B-NP
caagacgagg	caagacgagg	NN	B-NP
1620	1620	FW	0
cagcgcggct	cagcgcggct	NN	B-NP
atcgtggctg	atcgtggctg	NN	B-NP
gccacgacgg	gccacgacgg	NN	B-NP
gcgttccttg	gcgttccttg	NN	B-NP
cgcagctgtg	cgcagctgtg	NN	B-NP
ctcgacgttg	ctcgacgttg	NN	B-NP
1680	1680	FW	0
tcactgaagc	tcactgaagc	NN	B-NP
gggaagggac	gggaagggac	NN	B-NP
tggctgctat	tggctgctat	NN	B-NP
tgggcgaagt	tgggcgaagt	NN	B-NP
gccggggcag	gccggggcag	NN	B-NP
gatctcctgt	gatctcctgt	NN	B-NP
1740	1740	FW	0
catctcacct	catctcacct	NN	B-NP
tgctcctgcc	tgctcctgcc	NN	B-NP
gagaaagtat	gagaaagtat	NN	B-NP
ccatcatggc	ccatcatggc	NN	B-NP
tgatgcaatg	tgatgcaatg	NN	B-NP
cggcggctgc	cggcggctgc	NN	B-NP
1800	1800	FW	0
atacgcttga	atacgcttga	NN	B-NP
tccggctacc	tccggctacc	NN	B-NP
tgcccattcg	tgcccattcg	NN	B-NP
accaccaagc	accaccaagc	NN	B-NP
gaaacatcgc	gaaacatcgc	NN	B-NP
atcgagcgag	atcgagcgag	NN	B-NP
1860	1860	FW	0
cacgtactcg	cacgtactcg	NN	B-NP
gatggaagcc	gatggaagcc	NN	B-NP
ggtcttgtcg	ggtcttgtcg	NN	B-NP
atcaggatga	atcaggatga	NN	B-NP
tctggacgaa	tctggacgaa	NN	B-NP
gagcatcagg	gagcatcagg	NN	B-NP
1920	1920	FW	0
ggctcgcgcc	ggctcgcgcc	NN	B-NP
agccgaactg	agccgaactg	NN	B-NP
ttcgccaggc	ttcgccaggc	NN	B-NP
tcaaggcgag	tcaaggcgag	NN	B-NP
catgcccgac	catgcccgac	NN	B-NP
ggcgaggatc	ggcgaggatc	NN	B-NP
1980	1980	FW	0
tcgtcgtgac	tcgtcgtgac	NN	B-NP
ccatggcgat	ccatggcgat	NN	B-NP
gcctgcttgc	gcctgcttgc	NN	B-NP
cgaatatcat	cgaatatcat	NN	B-NP
ggtggaaaat	ggtggaaaat	NN	B-NP
ggccgctttt	ggccgctttt	NN	B-NP
2040	2040	FW	0
ctggattcat	ctggattcat	NN	B-NP
cgactgtggc	cgactgtggc	NN	B-NP
cggctgggtg	cggctgggtg	NN	B-NP
tggcggaccg	tggcggaccg	NN	B-NP
ctatcaggac	ctatcaggac	NN	B-NP
atagcgttgg	atagcgttgg	NN	B-NP
2100	2100	FW	0
ctacccgtga	ctacccgtga	NN	B-NP
tattgctgaa	tattgctgaa	NN	B-NP
gagcttggcg	gagcttggcg	NN	B-NP
gcgaatgggc	gcgaatgggc	NN	B-NP
tgaccgcttc	tgaccgcttc	NN	B-NP
ctcgtgcttt	ctcgtgcttt	NN	B-NP
2160	2160	FW	0
acggtatcgc	acggtatcgc	NN	B-NP
cgctcccgat	cgctcccgat	NN	B-NP
tcgcagcgca	tcgcagcgca	NN	B-NP
tcgccttcta	tcgccttcta	NN	B-NP
tcgccttctt	tcgccttctt	NN	B-NP
gacgagttct	gacgagttct	NN	B-NP
2220	2220	FW	0
tctgaattat	tctgaattat	NN	B-NP
taacgcttac	taacgcttac	NN	B-NP
aatttcctga	aatttcctga	NN	B-NP
tgcggtattt	tgcggtattt	NN	B-NP
tctccttacg	tctccttacg	NN	B-NP
catctgtgcg	catctgtgcg	NN	B-NP
2280	2280	FW	0
gtatttcaca	gtatttcaca	NN	B-NP
ccgcatcagg	ccgcatcagg	NN	B-NP
tggcactttt	tggcactttt	NN	B-NP
cggggaaatg	cggggaaatg	NN	B-NP
tgcgcggaac	tgcgcggaac	NN	B-NP
ccctatttgt	ccctatttgt	NN	B-NP
2340	2340	FW	0
ttatttttct	ttatttttct	NN	B-NP
aaatacattc	aaatacattc	NN	B-NP
aaatatgtat	aaatatgtat	NN	B-NP
ccgctcatga	ccgctcatga	NN	B-NP
gacaataacc	gacaataacc	NN	B-NP
ctgataaatg	ctgataaatg	NN	B-NP
2400	2400	FW	0
cttcaataat	cttcaataat	NN	B-NP
agcacgtgct	agcacgtgct	NN	B-NP
aaaacttcat	aaaacttcat	NN	B-NP
ttttaattta	ttttaattta	NN	B-NP
aaaggatcta	aaaggatcta	NN	B-NP
ggtgaagatc	ggtgaagatc	NN	B-NP
2460	2460	FW	0
ctttttgata	ctttttgata	NN	B-NP
atctccggaa	atctccggaa	NN	B-NP
gagtcaagaa	gagtcaagaa	NN	B-NP
catgtgagca	catgtgagca	NN	B-NP
aaaggccagc	aaaggccagc	NN	B-NP
aaaaggccag	aaaaggccag	NN	B-NP
2520	2520	FW	0
gaaccgtaaa	gaaccgtaaa	NN	B-NP
aaggccgcgt	aaggccgcgt	NN	B-NP
tgctggcgtt	tgctggcgtt	NN	B-NP
tttccatagg	tttccatagg	NN	B-NP
ctccgccccc	ctccgccccc	NN	B-NP
ctgacgagca	ctgacgagca	NN	B-NP
2580	2580	FW	0
tcacaaaaat	tcacaaaaat	NN	B-NP
cgacgctcaa	cgacgctcaa	NN	B-NP
gtcagaggtg	gtcagaggtg	NN	B-NP
gcgaaacccg	gcgaaacccg	NN	B-NP
acaggactat	acaggactat	NN	B-NP
aaagatacca	aaagatacca	NN	B-NP
2640	2640	FW	0
ggcgtttccc	ggcgtttccc	NN	B-NP
cctggaagct	cctggaagct	NN	B-NP
ccctcgtgcg	ccctcgtgcg	NN	B-NP
ctctcctgtt	ctctcctgtt	NN	B-NP
ccgaccctgc	ccgaccctgc	NN	B-NP
cgcttaccgg	cgcttaccgg	NN	B-NP
2700	2700	FW	0
atacctgtcc	atacctgtcc	NN	B-NP
gcctttctcc	gcctttctcc	NN	B-NP
cttcgggaag	cttcgggaag	NN	B-NP
cgtggcgctt	cgtggcgctt	NN	B-NP
tctcatagct	tctcatagct	NN	B-NP
cacgctgtag	cacgctgtag	NN	B-NP
2760	2760	FW	0
gtatctcagt	gtatctcagt	NN	B-NP
tcggtgtagg	tcggtgtagg	NN	B-NP
tcgttcgctc	tcgttcgctc	NN	B-NP
caagctgggc	caagctgggc	NN	B-NP
tgtgtgcacg	tgtgtgcacg	NN	B-NP
aaccccccgt	aaccccccgt	NN	B-NP
2820	2820	FW	0
tcagcccgac	tcagcccgac	NN	B-NP
cgctgcgcct	cgctgcgcct	NN	B-NP
tatccggtaa	tatccggtaa	NN	B-NP
ctatcgtctt	ctatcgtctt	NN	B-NP
gagtccaacc	gagtccaacc	NN	B-NP
cggtaagaca	cggtaagaca	NN	B-NP
2880	2880	FW	0
cgacttatcg	cgacttatcg	NN	B-NP
ccactggcag	ccactggcag	NN	B-NP
cagccactgg	cagccactgg	NN	B-NP
taacaggatt	taacaggatt	NN	B-NP
agcagagcga	agcagagcga	NN	B-NP
ggtatgtagg	ggtatgtagg	NN	B-NP
2940	2940	FW	0
cggtgctaca	cggtgctaca	NN	B-NP
gagttcttga	gagttcttga	NN	B-NP
agtggtggcc	agtggtggcc	NN	B-NP
taactacggc	taactacggc	NN	B-NP
tacactagaa	tacactagaa	NN	B-NP
gaacagtatt	gaacagtatt	NN	B-NP
3000	3000	FW	0
tggtatctgc	tggtatctgc	NN	B-NP
gctctgctga	gctctgctga	NN	B-NP
agccagttac	agccagttac	NN	B-NP
cttcggaaaa	cttcggaaaa	NN	B-NP
agagttggta	agagttggta	NN	B-NP
gctcttgatc	gctcttgatc	NN	B-NP
3060	3060	FW	0
cggcaaacaa	cggcaaacaa	NN	B-NP
accaccgctg	accaccgctg	NN	B-NP
gtagcggtgg	gtagcggtgg	NN	B-NP
tttttttgtt	tttttttgtt	NN	B-NP
tgcaagcagc	tgcaagcagc	NN	B-NP
agattacgcg	agattacgcg	NN	B-NP
3120	3120	FW	0
cagaaaaaaa	cagaaaaaaa	NN	B-NP
ggatctcaag	ggatctcaag	NN	B-NP
aagatccttt	aagatccttt	NN	B-NP
gatcttttct	gatcttttct	NN	B-NP
acggggtctg	acggggtctg	NN	B-NP
acgctcagtg	acgctcagtg	NN	B-NP
3180	3180	FW	0
gaacgaaaac	gaacgaaaac	NN	B-NP
tcacgttaag	tcacgttaag	NN	B-NP
ggattttggt	ggattttggt	NN	B-NP
ccggccggaa	ccggccggaa	NN	B-NP
acgtttggtt	acgtttggtt	NN	B-NP
gctgactaat	gctgactaat	NN	B-NP
3240	3240	FW	0
tgagatgcat	tgagatgcat	NN	B-NP
gctttgcata	gctttgcata	NN	B-NP
cttctgcctg	cttctgcctg	NN	B-NP
ctggggagcc	ctggggagcc	NN	B-NP
tggggacttt	tggggacttt	NN	B-NP
ccacacctcg	ccacacctcg	NN	B-NP
3300	3300	FW	0
cgatgtacgg	cgatgtacgg	NN	B-NP
gccag	gccag	JJ	B-NP
3315	3315	CD	0
20	20	CD	0
3596	3596	CD	0
DNA	DNA	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Plasmid	Plasmid	NNP	I-NP
20	20	CD	0
gttgacattg	gttgacattg	NN	B-NP
attattgact	attattgact	NN	B-NP
agttattaat	agttattaat	NN	B-NP
agtaatcaat	agtaatcaat	NN	B-NP
tacggggtca	tacggggtca	NN	B-NP
ttagttcata	ttagttcata	NN	B-NP
60	60	NNP	0
gcccatatat	gcccatatat	NN	B-NP
ggagttccgc	ggagttccgc	NN	B-NP
gttacataac	gttacataac	NN	B-NP
ttacggtaaa	ttacggtaaa	NN	B-NP
tggcccgcct	tggcccgcct	NN	B-NP
ggctgaccgc	ggctgaccgc	NN	B-NP
120	120	FW	0
ccaacgaccc	ccaacgaccc	NN	B-NP
ccgcccattg	ccgcccattg	NN	B-NP
acgtcaataa	acgtcaataa	NN	B-NP
tgacgtatgt	tgacgtatgt	NN	B-NP
tcccatagta	tcccatagta	NN	B-NP
acgccaatag	acgccaatag	NN	B-NP
180	180	FW	0
ggactttcca	ggactttcca	NN	B-NP
ttgacgtcaa	ttgacgtcaa	NN	B-NP
tgggtggagt	tgggtggagt	NN	B-NP
atttacggta	atttacggta	NN	B-NP
aactgcccac	aactgcccac	NN	B-NP
ttggcagtac	ttggcagtac	NN	B-NP
240	240	FW	0
atcaagtgta	atcaagtgta	NN	B-NP
tcatatgcca	tcatatgcca	NN	B-NP
agtacgcccc	agtacgcccc	NN	B-NP
ctattgacgt	ctattgacgt	NN	B-NP
caatgacggt	caatgacggt	NN	B-NP
aaatggcccg	aaatggcccg	NN	B-NP
300	300	FW	0
cctggcatta	cctggcatta	NN	B-NP
tgcccagtac	tgcccagtac	NN	B-NP
atgaccttat	atgaccttat	NN	B-NP
gggactttcc	gggactttcc	NN	B-NP
tacttggcag	tacttggcag	NN	B-NP
tacatctacg	tacatctacg	NN	B-NP
360	360	FW	0
tattagtcat	tattagtcat	NN	B-NP
cgctattacc	cgctattacc	NN	B-NP
atggtgatgc	atggtgatgc	NN	B-NP
ggttttggca	ggttttggca	NN	B-NP
gtacatcaat	gtacatcaat	NN	B-NP
gggcgtggat	gggcgtggat	NN	B-NP
420	420	FW	0
agcggtttga	agcggtttga	NN	B-NP
ctcacgggga	ctcacgggga	NN	B-NP
tttccaagtc	tttccaagtc	NN	B-NP
tccaccccat	tccaccccat	NN	B-NP
tgacgtcaat	tgacgtcaat	NN	B-NP
gggagtttgt	gggagtttgt	NN	B-NP
480	480	FW	0
tttggcacca	tttggcacca	NN	B-NP
aaatcaacgg	aaatcaacgg	NN	B-NP
gactttccaa	gactttccaa	NN	B-NP
aatgtcgtaa	aatgtcgtaa	NN	B-NP
caactccgcc	caactccgcc	NN	B-NP
ccattgacgc	ccattgacgc	NN	B-NP
540	540	FW	0
aaatgggcgg	aaatgggcgg	NN	B-NP
taggcgtgta	taggcgtgta	NN	B-NP
cggtgggagg	cggtgggagg	NN	B-NP
tctatataag	tctatataag	NN	B-NP
cagagctctc	cagagctctc	NN	B-NP
tggctaacta	tggctaacta	NN	B-NP
600	600	FW	0
gagaacccac	gagaacccac	NN	B-NP
tgcttactgg	tgcttactgg	NN	B-NP
cttatcgaaa	cttatcgaaa	NN	B-NP
ttaatacgac	ttaatacgac	NN	B-NP
tcactatagg	tcactatagg	NN	B-NP
gagacccaag	gagacccaag	NN	B-NP
660	660	FW	0
ctggctagcg	ctggctagcg	NN	B-NP
tttaaactta	tttaaactta	NN	B-NP
agccaccatg	agccaccatg	NN	B-NP
tccctgttga	tccctgttga	NN	B-NP
tgtggatcac	tgtggatcac	NN	B-NP
gcagtgcaaa	gcagtgcaaa	NN	B-NP
720	720	FW	0
gcttcggaga	gcttcggaga	NN	B-NP
aaatcttcta	aaatcttcta	NN	B-NP
tgtgggtctt	tgtgggtctt	NN	B-NP
ccaagtattc	ccaagtattc	NN	B-NP
ctgttcatcc	ctgttcatcc	NN	B-NP
aattggtctt	aattggtctt	NN	B-NP
780	780	FW	0
ccaagtattc	ccaagtattc	NN	B-NP
ctgttcatcc	ctgttcatcc	NN	B-NP
aattaaagct	aattaaagct	NN	B-NP
tcggagaaaa	tcggagaaaa	NN	B-NP
tcttctatgt	tcttctatgt	NN	B-NP
gtccctgttg	gtccctgttg	NN	B-NP
840	840	FW	0
atgtggatca	atgtggatca	NN	B-NP
cgcagtgcaa	cgcagtgcaa	NN	B-NP
agcttcggag	agcttcggag	NN	B-NP
aaaatcttct	aaaatcttct	NN	B-NP
atgtgaaagc	atgtgaaagc	NN	B-NP
ttcggagaaa	ttcggagaaa	NN	B-NP
900	900	FW	0
atcttctacg	atcttctacg	NN	B-NP
tacggtgcgg	tacggtgcgg	NN	B-NP
tgccaggggg	tgccaggggg	NN	B-NP
ccggagagcc	ccggagagcc	NN	B-NP
gcctgcttga	gcctgcttga	NN	B-NP
gttctacctc	gttctacctc	NN	B-NP
960	960	FW	0
gccatgcctt	gccatgcctt	NN	B-NP
tcgcgacacc	tcgcgacacc	NN	B-NP
catggaagca	catggaagca	NN	B-NP
gagctggccc	gagctggccc	NN	B-NP
gcaggagcct	gcaggagcct	NN	B-NP
ggcccaggat	ggcccaggat	NN	B-NP
1020	1020	FW	0
gccccaccgc	gccccaccgc	NN	B-NP
ttcccgtgcc	ttcccgtgcc	NN	B-NP
aggggtgctt	aggggtgctt	NN	B-NP
ctgaaggagt	ctgaaggagt	NN	B-NP
tcactgtgtc	tcactgtgtc	NN	B-NP
cggcaacata	cggcaacata	NN	B-NP
1080	1080	FW	0
ctgactatcc	ctgactatcc	NN	B-NP
gactgactgc	gactgactgc	NN	B-NP
tgcagaccac	tgcagaccac	NN	B-NP
cgccaactgc	cgccaactgc	NN	B-NP
agctctccat	agctctccat	NN	B-NP
cagctcctgt	cagctcctgt	NN	B-NP
1140	1140	FW	0
ctccagcagc	ctccagcagc	NN	B-NP
tttccctgtt	tttccctgtt	NN	B-NP
gatgtggatc	gatgtggatc	NN	B-NP
acgcagtgct	acgcagtgct	NN	B-NP
ttctgcccgt	ttctgcccgt	NN	B-NP
gtttttggct	gtttttggct	NN	B-NP
1200	1200	FW	0
cagcctccct	cagcctccct	NN	B-NP
cagggcagag	cagggcagag	NN	B-NP
gcgctagtga	gcgctagtga	NN	B-NP
gaattctgca	gaattctgca	NN	B-NP
gatatccatc	gatatccatc	NN	B-NP
acactggcgg	acactggcgg	NN	B-NP
1260	1260	FW	0
ccgctcgagt	ccgctcgagt	NN	B-NP
ctagagggcc	ctagagggcc	NN	B-NP
cgtttaaacc	cgtttaaacc	NN	B-NP
cgctgatcag	cgctgatcag	NN	B-NP
cctcgactgt	cctcgactgt	NN	B-NP
gccttctagt	gccttctagt	NN	B-NP
1320	1320	FW	0
tgccagccat	tgccagccat	NN	B-NP
ctgttgtttg	ctgttgtttg	NN	B-NP
cccctccccc	cccctccccc	NN	B-NP
gtgccttcct	gtgccttcct	NN	B-NP
tgaccctgga	tgaccctgga	NN	B-NP
aggtgccact	aggtgccact	NN	B-NP
1380	1380	FW	0
cccactgtcc	cccactgtcc	NN	B-NP
tttcctaata	tttcctaata	NN	B-NP
aaatgaggaa	aaatgaggaa	NN	B-NP
attgcatcgc	attgcatcgc	NN	B-NP
attgtctgag	attgtctgag	NN	B-NP
taggtgtcat	taggtgtcat	NN	B-NP
1440	1440	FW	0
tctattctgg	tctattctgg	NN	B-NP
ggggtggggt	ggggtggggt	NN	B-NP
ggggcaggac	ggggcaggac	NN	B-NP
agcaaggggg	agcaaggggg	NN	B-NP
aggattggga	aggattggga	NN	B-NP
agacaatagc	agacaatagc	NN	B-NP
1500	1500	FW	0
aggcatgctg	aggcatgctg	NN	B-NP
gggatgcggt	gggatgcggt	NN	B-NP
gggctctatg	gggctctatg	NN	B-NP
gcttctactg	gcttctactg	NN	B-NP
ggcggtttta	ggcggtttta	NN	B-NP
tggacagcaa	tggacagcaa	NN	B-NP
1560	1560	FW	0
gcgaaccgga	gcgaaccgga	NN	B-NP
attgccagct	attgccagct	NN	B-NP
ggggcgccct	ggggcgccct	NN	B-NP
ctggtaaggt	ctggtaaggt	NN	B-NP
tgggaagccc	tgggaagccc	NN	B-NP
tgcaaagtaa	tgcaaagtaa	NN	B-NP
1620	1620	FW	0
actggatggc	actggatggc	NN	B-NP
tttcttgccg	tttcttgccg	NN	B-NP
ccaaggatct	ccaaggatct	NN	B-NP
gatggcgcag	gatggcgcag	NN	B-NP
gggatcaagc	gggatcaagc	NN	B-NP
tctgatcaag	tctgatcaag	NN	B-NP
1680	1680	FW	0
agacaggatg	agacaggatg	NN	B-NP
aggatcgttt	aggatcgttt	NN	B-NP
cgcatgattg	cgcatgattg	NN	B-NP
aacaagatgg	aacaagatgg	NN	B-NP
attgcacgca	attgcacgca	NN	B-NP
ggttctccgg	ggttctccgg	NN	B-NP
1740	1740	FW	0
ccgcttgggt	ccgcttgggt	NN	B-NP
ggagaggcta	ggagaggcta	NN	B-NP
ttcggctatg	ttcggctatg	NN	B-NP
actgggcaca	actgggcaca	NN	B-NP
acagacaatc	acagacaatc	NN	B-NP
ggctgctctg	ggctgctctg	NN	B-NP
1800	1800	FW	0
atgccgccgt	atgccgccgt	NN	B-NP
gttccggctg	gttccggctg	NN	B-NP
tcagcgcagg	tcagcgcagg	NN	B-NP
ggcgcccggt	ggcgcccggt	NN	B-NP
tctttttgtc	tctttttgtc	NN	B-NP
aagaccgacc	aagaccgacc	NN	B-NP
1860	1860	FW	0
tgtccggtgc	tgtccggtgc	NN	B-NP
cctgaatgaa	cctgaatgaa	NN	B-NP
ctgcaagacg	ctgcaagacg	NN	B-NP
aggcagcgcg	aggcagcgcg	NN	B-NP
gctatcgtgg	gctatcgtgg	NN	B-NP
ctggccacga	ctggccacga	NN	B-NP
1920	1920	FW	0
cgggcgttcc	cgggcgttcc	NN	B-NP
ttgcgcagct	ttgcgcagct	NN	B-NP
gtgctcgacg	gtgctcgacg	NN	B-NP
ttgtcactga	ttgtcactga	NN	B-NP
agcgggaagg	agcgggaagg	NN	B-NP
gactggctgc	gactggctgc	NN	B-NP
1980	1980	FW	0
tattgggcga	tattgggcga	NN	B-NP
agtgccgggg	agtgccgggg	NN	B-NP
caggatctcc	caggatctcc	NN	B-NP
tgtcatctca	tgtcatctca	NN	B-NP
ccttgctcct	ccttgctcct	NN	B-NP
gccgagaaag	gccgagaaag	NN	B-NP
2040	2040	FW	0
tatccatcat	tatccatcat	NN	B-NP
ggctgatgca	ggctgatgca	NN	B-NP
atgcggcggc	atgcggcggc	NN	B-NP
tgcatacgct	tgcatacgct	NN	B-NP
tgatccggct	tgatccggct	NN	B-NP
acctgcccat	acctgcccat	NN	B-NP
2100	2100	FW	0
tcgaccacca	tcgaccacca	NN	B-NP
agcgaaacat	agcgaaacat	NN	B-NP
cgcatcgagc	cgcatcgagc	NN	B-NP
gagcacgtac	gagcacgtac	NN	B-NP
tcggatggaa	tcggatggaa	NN	B-NP
gccggtcttg	gccggtcttg	NN	B-NP
2160	2160	FW	0
tcgatcagga	tcgatcagga	NN	B-NP
tgatctggac	tgatctggac	NN	B-NP
gaagagcatc	gaagagcatc	NN	B-NP
aggggctcgc	aggggctcgc	NN	B-NP
gccagccgaa	gccagccgaa	NN	B-NP
ctgttcgcca	ctgttcgcca	NN	B-NP
2220	2220	FW	0
ggctcaaggc	ggctcaaggc	NN	B-NP
gagcatgccc	gagcatgccc	NN	B-NP
gacggcgagg	gacggcgagg	NN	B-NP
atctcgtcgt	atctcgtcgt	NN	B-NP
gacccatggc	gacccatggc	NN	B-NP
gatgcctgct	gatgcctgct	NN	B-NP
2280	2280	FW	0
tgccgaatat	tgccgaatat	NN	B-NP
catggtggaa	catggtggaa	NN	B-NP
aatggccgct	aatggccgct	NN	B-NP
tttctggatt	tttctggatt	NN	B-NP
catcgactgt	catcgactgt	NN	B-NP
ggccggctgg	ggccggctgg	NN	B-NP
2340	2340	FW	0
gtgtggcgga	gtgtggcgga	NN	B-NP
ccgctatcag	ccgctatcag	NN	B-NP
gacatagcgt	gacatagcgt	NN	B-NP
tggctacccg	tggctacccg	NN	B-NP
tgatattgct	tgatattgct	NN	B-NP
gaagagcttg	gaagagcttg	NN	B-NP
2400	2400	FW	0
gcggcgaatg	gcggcgaatg	NN	B-NP
ggctgaccgc	ggctgaccgc	NN	B-NP
ttcctcgtgc	ttcctcgtgc	NN	B-NP
tttacggtat	tttacggtat	NN	B-NP
cgccgctccc	cgccgctccc	NN	B-NP
gattcgcagc	gattcgcagc	NN	B-NP
2460	2460	FW	0
gcatcgcctt	gcatcgcctt	NN	B-NP
ctatcgcctt	ctatcgcctt	NN	B-NP
cttgacgagt	cttgacgagt	NN	B-NP
tcttctgaat	tcttctgaat	NN	B-NP
tattaacgct	tattaacgct	NN	B-NP
tacaatttcc	tacaatttcc	NN	B-NP
2520	2520	FW	0
tgatgcggta	tgatgcggta	NN	B-NP
ttttctcctt	ttttctcctt	NN	B-NP
acgcatctgt	acgcatctgt	NN	B-NP
gcggtatttc	gcggtatttc	NN	B-NP
acaccgcatc	acaccgcatc	NN	B-NP
aggtggcact	aggtggcact	NN	B-NP
2580	2580	FW	0
tttcggggaa	tttcggggaa	NN	B-NP
atgtgcgcgg	atgtgcgcgg	NN	B-NP
aacccctatt	aacccctatt	NN	B-NP
tgtttatttt	tgtttatttt	NN	B-NP
tctaaataca	tctaaataca	NN	B-NP
ttcaaatatg	ttcaaatatg	NN	B-NP
2640	2640	FW	0
tatccgctca	tatccgctca	NN	B-NP
tgagacaata	tgagacaata	NN	B-NP
accctgataa	accctgataa	NN	B-NP
atgcttcaat	atgcttcaat	NN	B-NP
aatagcacgt	aatagcacgt	NN	B-NP
gctaaaactt	gctaaaactt	NN	B-NP
2700	2700	FW	0
catttttaat	catttttaat	NN	B-NP
ttaaaaggat	ttaaaaggat	NN	B-NP
ctaggtgaag	ctaggtgaag	NN	B-NP
atcctttttg	atcctttttg	NN	B-NP
ataatctccg	ataatctccg	NN	B-NP
gaagagtcaa	gaagagtcaa	NN	B-NP
2760	2760	FW	0
gaacatgtga	gaacatgtga	NN	B-NP
gcaaaaggcc	gcaaaaggcc	NN	B-NP
agcaaaaggc	agcaaaaggc	NN	B-NP
caggaaccgt	caggaaccgt	NN	B-NP
aaaaaggccg	aaaaaggccg	NN	B-NP
cgttgctggc	cgttgctggc	NN	B-NP
2820	2820	FW	0
gtttttccat	gtttttccat	NN	B-NP
aggctccgcc	aggctccgcc	NN	B-NP
cccctgacga	cccctgacga	NN	B-NP
gcatcacaaa	gcatcacaaa	NN	B-NP
aatcgacgct	aatcgacgct	NN	B-NP
caagtcagag	caagtcagag	NN	B-NP
2880	2880	FW	0
gtggcgaaac	gtggcgaaac	NN	B-NP
ccgacaggac	ccgacaggac	NN	B-NP
tataaagata	tataaagata	NN	B-NP
ccaggcgttt	ccaggcgttt	NN	B-NP
ccccctggaa	ccccctggaa	NN	B-NP
gctccctcgt	gctccctcgt	NN	B-NP
2940	2940	FW	0
gcgctctcct	gcgctctcct	NN	B-NP
gttccgaccc	gttccgaccc	NN	B-NP
tgccgcttac	tgccgcttac	NN	B-NP
cggatacctg	cggatacctg	NN	B-NP
tccgcctttc	tccgcctttc	NN	B-NP
tcccttcggg	tcccttcggg	NN	B-NP
3000	3000	FW	0
aagcgtggcg	aagcgtggcg	NN	B-NP
ctttctcata	ctttctcata	NN	B-NP
gctcacgctg	gctcacgctg	NN	B-NP
taggtatctc	taggtatctc	NN	B-NP
agttcggtgt	agttcggtgt	NN	B-NP
aggtcgttcg	aggtcgttcg	NN	B-NP
3060	3060	FW	0
ctccaagctg	ctccaagctg	NN	B-NP
ggctgtgtgc	ggctgtgtgc	NN	B-NP
acgaaccccc	acgaaccccc	NN	B-NP
cgttcagccc	cgttcagccc	NN	B-NP
gaccgctgcg	gaccgctgcg	NN	B-NP
ccttatccgg	ccttatccgg	NN	B-NP
3120	3120	FW	0
taactatcgt	taactatcgt	NN	B-NP
cttgagtcca	cttgagtcca	NN	B-NP
acccggtaag	acccggtaag	NN	B-NP
acacgactta	acacgactta	NN	B-NP
tcgccactgg	tcgccactgg	NN	B-NP
cagcagccac	cagcagccac	NN	B-NP
3180	3180	FW	0
tggtaacagg	tggtaacagg	NN	B-NP
attagcagag	attagcagag	NN	B-NP
cgaggtatgt	cgaggtatgt	NN	B-NP
aggcggtgct	aggcggtgct	NN	B-NP
acagagttct	acagagttct	NN	B-NP
tgaagtggtg	tgaagtggtg	NN	B-NP
3240	3240	FW	0
gcctaactac	gcctaactac	NN	B-NP
ggctacacta	ggctacacta	NN	B-NP
gaagaacagt	gaagaacagt	NN	B-NP
atttggtatc	atttggtatc	NN	B-NP
tgcgctctgc	tgcgctctgc	NN	B-NP
tgaagccagt	tgaagccagt	NN	B-NP
3300	3300	FW	0
taccttcgga	taccttcgga	NN	B-NP
aaaagagttg	aaaagagttg	NN	B-NP
gtagctcttg	gtagctcttg	NN	B-NP
atccggcaaa	atccggcaaa	NN	B-NP
caaaccaccg	caaaccaccg	NN	B-NP
ctggtagcgg	ctggtagcgg	NN	B-NP
3360	3360	FW	0
tggttttttt	tggttttttt	NN	B-NP
gtttgcaagc	gtttgcaagc	NN	B-NP
agcagattac	agcagattac	NN	B-NP
gcgcagaaaa	gcgcagaaaa	NN	B-NP
aaaggatctc	aaaggatctc	NN	B-NP
aagaagatcc	aagaagatcc	NN	B-NP
3420	3420	FW	0
tttgatcttt	tttgatcttt	NN	B-NP
tctacggggt	tctacggggt	NN	B-NP
ctgacgctca	ctgacgctca	NN	B-NP
gtggaacgaa	gtggaacgaa	NN	B-NP
aactcacgtt	aactcacgtt	NN	B-NP
aagggatttt	aagggatttt	NN	B-NP
3480	3480	FW	0
ggtccggccg	ggtccggccg	NN	B-NP
gaaacgtttg	gaaacgtttg	NN	B-NP
gttgctgact	gttgctgact	NN	B-NP
aattgagatg	aattgagatg	NN	B-NP
catgctttgc	catgctttgc	NN	B-NP
atacttctgc	atacttctgc	NN	B-NP
3540	3540	FW	0
ctgctgggga	ctgctgggga	NN	B-NP
gcctggggac	gcctggggac	NN	B-NP
tttccacacc	tttccacacc	NN	B-NP
tcgcgatgta	tcgcgatgta	NN	B-NP
cgggccagat	cgggccagat	NN	B-NP
atacgc	atacgc	JJ	B-NP
3596	3596	CD	0
21	21	CD	0
3884	3884	CD	0
DNA	DNA	NNP	B-NP
Artificial	Artificial	NNP	I-NP
Sequence	Sequence	NNP	I-NP
Plasmid	Plasmid	NNP	I-NP
21	21	CD	0
cgttgacatt	cgttgacatt	NN	B-NP
gattattgac	gattattgac	NN	B-NP
tagttattaa	tagttattaa	NN	B-NP
tagtaatcaa	tagtaatcaa	NN	B-NP
ttacggggtc	ttacggggtc	NN	B-NP
attagttcat	attagttcat	NN	B-NP
60	60	NNP	0
agcccatata	agcccatata	NN	B-NP
tggagttccg	tggagttccg	NN	B-NP
cgttacataa	cgttacataa	NN	B-NP
cttacggtaa	cttacggtaa	NN	B-NP
atggcccgcc	atggcccgcc	NN	B-NP
tggctgaccg	tggctgaccg	NN	B-NP
120	120	FW	0
cccaacgacc	cccaacgacc	NN	B-NP
cccgcccatt	cccgcccatt	NN	B-NP
gacgtcaata	gacgtcaata	NN	B-NP
atgacgtatg	atgacgtatg	NN	B-NP
ttcccatagt	ttcccatagt	NN	B-NP
aacgccaata	aacgccaata	NN	B-NP
180	180	FW	0
gggactttcc	gggactttcc	NN	B-NP
attgacgtca	attgacgtca	NN	B-NP
atgggtggag	atgggtggag	NN	B-NP
tatttacggt	tatttacggt	NN	B-NP
aaactgccca	aaactgccca	NN	B-NP
cttggcagta	cttggcagta	NN	B-NP
240	240	FW	0
catcaagtgt	catcaagtgt	NN	B-NP
atcatatgcc	atcatatgcc	NN	B-NP
aagtacgccc	aagtacgccc	NN	B-NP
cctattgacg	cctattgacg	NN	B-NP
tcaatgacgg	tcaatgacgg	NN	B-NP
taaatggccc	taaatggccc	NN	B-NP
300	300	FW	0
gcctggcatt	gcctggcatt	NN	B-NP
atgcccagta	atgcccagta	NN	B-NP
catgacctta	catgacctta	NN	B-NP
tgggactttc	tgggactttc	NN	B-NP
ctacttggca	ctacttggca	NN	B-NP
gtacatctac	gtacatctac	NN	B-NP
360	360	FW	0
gtattagtca	gtattagtca	NN	B-NP
tcgctattac	tcgctattac	NN	B-NP
catggtgatg	catggtgatg	NN	B-NP
cggttttggc	cggttttggc	NN	B-NP
agtacatcaa	agtacatcaa	NN	B-NP
tgggcgtgga	tgggcgtgga	NN	B-NP
420	420	FW	0
tagcggtttg	tagcggtttg	NN	B-NP
actcacgggg	actcacgggg	NN	B-NP
atttccaagt	atttccaagt	NN	B-NP
ctccacccca	ctccacccca	NN	B-NP
ttgacgtcaa	ttgacgtcaa	NN	B-NP
tgggagtttg	tgggagtttg	NN	B-NP
480	480	FW	0
ttttggcacc	ttttggcacc	NN	B-NP
aaaatcaacg	aaaatcaacg	NN	B-NP
ggactttcca	ggactttcca	NN	B-NP
aaatgtcgta	aaatgtcgta	NN	B-NP
acaactccgc	acaactccgc	NN	B-NP
cccattgacg	cccattgacg	NN	B-NP
540	540	FW	0
caaatgggcg	caaatgggcg	NN	B-NP
gtaggcgtgt	gtaggcgtgt	NN	B-NP
acggtgggag	acggtgggag	NN	B-NP
gtctatataa	gtctatataa	NN	B-NP
gcagagctct	gcagagctct	NN	B-NP
ctggctaact	ctggctaact	NN	B-NP
600	600	FW	0
agagaaccca	agagaaccca	NN	B-NP
ctgcttactg	ctgcttactg	NN	B-NP
gcttatcgaa	gcttatcgaa	NN	B-NP
attaatacga	attaatacga	NN	B-NP
ctcactatag	ctcactatag	NN	B-NP
ggagacccaa	ggagacccaa	NN	B-NP
660	660	FW	0
gctggctagc	gctggctagc	NN	B-NP
gtttaaactt	gtttaaactt	NN	B-NP
aagccaccat	aagccaccat	NN	B-NP
gaatctcctt	gaatctcctt	NN	B-NP
cacgaaaccg	cacgaaaccg	NN	B-NP
actcggctgt	actcggctgt	NN	B-NP
720	720	FW	0
ggccaccgcg	ggccaccgcg	NN	B-NP
cgccgcccgc	cgccgcccgc	NN	B-NP
gctggctgtg	gctggctgtg	NN	B-NP
cgctggggcg	cgctggggcg	NN	B-NP
ctggtgctgg	ctggtgctgg	NN	B-NP
cgggtggctt	cgggtggctt	NN	B-NP
780	780	FW	0
ctttctcctc	ctttctcctc	NN	B-NP
ggcttcctct	ggcttcctct	NN	B-NP
tcgggtggtt	tcgggtggtt	NN	B-NP
tataaaaagc	tataaaaagc	NN	B-NP
gctcagctgg	gctcagctgg	NN	B-NP
caggggccaa	caggggccaa	NN	B-NP
840	840	FW	0
aggagtcatt	aggagtcatt	NN	B-NP
ctctactccg	ctctactccg	NN	B-NP
accctgctga	accctgctga	NN	B-NP
ctactttgct	ctactttgct	NN	B-NP
cctggggtga	cctggggtga	NN	B-NP
agtcctatcc	agtcctatcc	NN	B-NP
900	900	FW	0
agatggttgg	agatggttgg	NN	B-NP
aatcttcctg	aatcttcctg	NN	B-NP
gaggtggtgt	gaggtggtgt	NN	B-NP
ccagcgtgga	ccagcgtgga	NN	B-NP
aatatcctaa	aatatcctaa	NN	B-NP
atctgaatgg	atctgaatgg	NN	B-NP
960	960	FW	0
tgcaggagac	tgcaggagac	NN	B-NP
cctctcacac	cctctcacac	NN	B-NP
caggttaccc	caggttaccc	NN	B-NP
agcaaatgaa	agcaaatgaa	NN	B-NP
tatgcttata	tatgcttata	NN	B-NP
ggcgtggaat	ggcgtggaat	NN	B-NP
1020	1020	FW	0
tgcagaggct	tgcagaggct	NN	B-NP
gttggtcttc	gttggtcttc	NN	B-NP
caagtattcc	caagtattcc	NN	B-NP
tgttcatcct	tgttcatcct	NN	B-NP
attgccctgc	attgccctgc	NN	B-NP
agagtctctt	agagtctctt	NN	B-NP
1080	1080	FW	0
gcagcacctc	gcagcacctc	NN	B-NP
atcgggctga	atcgggctga	NN	B-NP
gcaatctgac	gcaatctgac	NN	B-NP
ccacgtgctg	ccacgtgctg	NN	B-NP
tatcctgtcc	tatcctgtcc	NN	B-NP
ccctggagag	ccctggagag	NN	B-NP
1140	1140	FW	0
ttatgaggac	ttatgaggac	NN	B-NP
atccatggta	atccatggta	NN	B-NP
ccctccacct	ccctccacct	NN	B-NP
ggagaggctt	ggagaggctt	NN	B-NP
gcctatctgc	gcctatctgc	NN	B-NP
atgccaggct	atgccaggct	NN	B-NP
1200	1200	FW	0
cagggagttg	cagggagttg	NN	B-NP
ctgtgtgagt	ctgtgtgagt	NN	B-NP
tggggcggcc	tggggcggcc	NN	B-NP
cagcatggtc	cagcatggtc	NN	B-NP
tggcttagtg	tggcttagtg	NN	B-NP
ccaacccctg	ccaacccctg	NN	B-NP
1260	1260	FW	0
tcctcactgt	tcctcactgt	NN	B-NP
ggggacagaa	ggggacagaa	NN	B-NP
ccttctatga	ccttctatga	NN	B-NP
cccggagccc	cccggagccc	NN	B-NP
atcctgtgcc	atcctgtgcc	NN	B-NP
cctgtttcat	cctgtttcat	NN	B-NP
1320	1320	FW	0
gcctaacaag	gcctaacaag	NN	B-NP
cgatcgctcc	cgatcgctcc	NN	B-NP
tgcaacacct	tgcaacacct	NN	B-NP
catcgggctg	catcgggctg	NN	B-NP
ggggacgccg	ggggacgccg	NN	B-NP
cctacagtct	cctacagtct	NN	B-NP
1380	1380	FW	0
cctgcaacac	cctgcaacac	NN	B-NP
ctcatcgggc	ctcatcgggc	NN	B-NP
tgatttcccc	tgatttcccc	NN	B-NP
ggagaaggaa	ggagaaggaa	NN	B-NP
gagcagtata	gagcagtata	NN	B-NP
tcgccagtct	tcgccagtct	NN	B-NP
1440	1440	FW	0
cctgcaacac	cctgcaacac	NN	B-NP
ctcatcgggc	ctcatcgggc	NN	B-NP
tgaagaggcc	tgaagaggcc	NN	B-NP
aagtattaag	aagtattaag	NN	B-NP
aggggtcttc	aggggtcttc	NN	B-NP
caagtattcc	caagtattcc	NN	B-NP
1500	1500	FW	0
tgttcatcca	tgttcatcca	NN	B-NP
gtttagtgag	gtttagtgag	NN	B-NP
aattctgcag	aattctgcag	NN	B-NP
atatccatca	atatccatca	NN	B-NP
cactggcggc	cactggcggc	NN	B-NP
cgctcgagtc	cgctcgagtc	NN	B-NP
1560	1560	FW	0
tagagggccc	tagagggccc	NN	B-NP
gtttaaaccc	gtttaaaccc	NN	B-NP
gctgatcagc	gctgatcagc	NN	B-NP
ctcgactgtg	ctcgactgtg	NN	B-NP
ccttctagtt	ccttctagtt	NN	B-NP
gccagccatc	gccagccatc	NN	B-NP
1620	1620	FW	0
tgttgtttgc	tgttgtttgc	NN	B-NP
ccctcccccg	ccctcccccg	NN	B-NP
tgccttcctt	tgccttcctt	NN	B-NP
gaccctggaa	gaccctggaa	NN	B-NP
ggtgccactc	ggtgccactc	NN	B-NP
ccactgtcct	ccactgtcct	NN	B-NP
1680	1680	FW	0
ttcctaataa	ttcctaataa	NN	B-NP
aatgaggaaa	aatgaggaaa	NN	B-NP
ttgcatcgca	ttgcatcgca	NN	B-NP
ttgtctgagt	ttgtctgagt	NN	B-NP
aggtgtcatt	aggtgtcatt	NN	B-NP
ctattctggg	ctattctggg	NN	B-NP
1740	1740	FW	0
gggtggggtg	gggtggggtg	NN	B-NP
gggcaggaca	gggcaggaca	NN	B-NP
gcaaggggga	gcaaggggga	NN	B-NP
ggattgggaa	ggattgggaa	NN	B-NP
gacaatagca	gacaatagca	NN	B-NP
ggcatgctgg	ggcatgctgg	NN	B-NP
1800	1800	FW	0
ggatgcggtg	ggatgcggtg	NN	B-NP
ggctctatgg	ggctctatgg	NN	B-NP
cttctactgg	cttctactgg	NN	B-NP
gcggttttat	gcggttttat	NN	B-NP
ggacagcaag	ggacagcaag	NN	B-NP
cgaaccggaa	cgaaccggaa	NN	B-NP
1860	1860	FW	0
ttgccagctg	ttgccagctg	NN	B-NP
gggcgccctc	gggcgccctc	NN	B-NP
tggtaaggtt	tggtaaggtt	NN	B-NP
gggaagccct	gggaagccct	NN	B-NP
gcaaagtaaa	gcaaagtaaa	NN	B-NP
ctggatggct	ctggatggct	NN	B-NP
1920	1920	FW	0
ttcttgccgc	ttcttgccgc	NN	B-NP
caaggatctg	caaggatctg	NN	B-NP
atggcgcagg	atggcgcagg	NN	B-NP
ggatcaagct	ggatcaagct	NN	B-NP
ctgatcaaga	ctgatcaaga	NN	B-NP
gacaggatga	gacaggatga	NN	B-NP
1980	1980	FW	0
ggatcgtttc	ggatcgtttc	NN	B-NP
gcatgattga	gcatgattga	NN	B-NP
acaagatgga	acaagatgga	NN	B-NP
ttgcacgcag	ttgcacgcag	NN	B-NP
gttctccggc	gttctccggc	NN	B-NP
cgcttgggtg	cgcttgggtg	NN	B-NP
2040	2040	FW	0
gagaggctat	gagaggctat	NN	B-NP
tcggctatga	tcggctatga	NN	B-NP
ctgggcacaa	ctgggcacaa	NN	B-NP
cagacaatcg	cagacaatcg	NN	B-NP
gctgctctga	gctgctctga	NN	B-NP
tgccgccgtg	tgccgccgtg	NN	B-NP
2100	2100	FW	0
ttccggctgt	ttccggctgt	NN	B-NP
cagcgcaggg	cagcgcaggg	NN	B-NP
gcgcccggtt	gcgcccggtt	NN	B-NP
ctttttgtca	ctttttgtca	NN	B-NP
agaccgacct	agaccgacct	NN	B-NP
gtccggtgcc	gtccggtgcc	NN	B-NP
2160	2160	FW	0
ctgaatgaac	ctgaatgaac	NN	B-NP
tgcaagacga	tgcaagacga	NN	B-NP
ggcagcgcgg	ggcagcgcgg	NN	B-NP
ctatcgtggc	ctatcgtggc	NN	B-NP
tggccacgac	tggccacgac	NN	B-NP
gggcgttcct	gggcgttcct	NN	B-NP
2220	2220	FW	0
tgcgcagctg	tgcgcagctg	NN	B-NP
tgctcgacgt	tgctcgacgt	NN	B-NP
tgtcactgaa	tgtcactgaa	NN	B-NP
gcgggaaggg	gcgggaaggg	NN	B-NP
actggctgct	actggctgct	NN	B-NP
attgggcgaa	attgggcgaa	NN	B-NP
2280	2280	FW	0
gtgccggggc	gtgccggggc	NN	B-NP
aggatctcct	aggatctcct	NN	B-NP
gtcatctcac	gtcatctcac	NN	B-NP
cttgctcctg	cttgctcctg	NN	B-NP
ccgagaaagt	ccgagaaagt	NN	B-NP
atccatcatg	atccatcatg	NN	B-NP
2340	2340	FW	0
gctgatgcaa	gctgatgcaa	NN	B-NP
tgcggcggct	tgcggcggct	NN	B-NP
gcatacgctt	gcatacgctt	NN	B-NP
gatccggcta	gatccggcta	NN	B-NP
cctgcccatt	cctgcccatt	NN	B-NP
cgaccaccaa	cgaccaccaa	NN	B-NP
2400	2400	FW	0
gcgaaacatc	gcgaaacatc	NN	B-NP
gcatcgagcg	gcatcgagcg	NN	B-NP
agcacgtact	agcacgtact	NN	B-NP
cggatggaag	cggatggaag	NN	B-NP
ccggtcttgt	ccggtcttgt	NN	B-NP
cgatcaggat	cgatcaggat	NN	B-NP
2460	2460	FW	0
gatctggacg	gatctggacg	NN	B-NP
aagagcatca	aagagcatca	NN	B-NP
ggggctcgcg	ggggctcgcg	NN	B-NP
ccagccgaac	ccagccgaac	NN	B-NP
tgttcgccag	tgttcgccag	NN	B-NP
gctcaaggcg	gctcaaggcg	NN	B-NP
2520	2520	FW	0
agcatgcccg	agcatgcccg	NN	B-NP
acggcgagga	acggcgagga	NN	B-NP
tctcgtcgtg	tctcgtcgtg	NN	B-NP
acccatggcg	acccatggcg	NN	B-NP
atgcctgctt	atgcctgctt	NN	B-NP
gccgaatatc	gccgaatatc	NN	B-NP
2580	2580	FW	0
atggtggaaa	atggtggaaa	NN	B-NP
atggccgctt	atggccgctt	NN	B-NP
ttctggattc	ttctggattc	NN	B-NP
atcgactgtg	atcgactgtg	NN	B-NP
gccggctggg	gccggctggg	NN	B-NP
tgtggcggac	tgtggcggac	NN	B-NP
2640	2640	FW	0
cgctatcagg	cgctatcagg	NN	B-NP
acatagcgtt	acatagcgtt	NN	B-NP
ggctacccgt	ggctacccgt	NN	B-NP
gatattgctg	gatattgctg	NN	B-NP
aagagcttgg	aagagcttgg	NN	B-NP
cggcgaatgg	cggcgaatgg	NN	B-NP
2700	2700	FW	0
gctgaccgct	gctgaccgct	NN	B-NP
tcctcgtgct	tcctcgtgct	NN	B-NP
ttacggtatc	ttacggtatc	NN	B-NP
gccgctcccg	gccgctcccg	NN	B-NP
attcgcagcg	attcgcagcg	NN	B-NP
catcgccttc	catcgccttc	NN	B-NP
2760	2760	FW	0
tatcgccttc	tatcgccttc	NN	B-NP
ttgacgagtt	ttgacgagtt	NN	B-NP
cttctgaatt	cttctgaatt	NN	B-NP
attaacgctt	attaacgctt	NN	B-NP
acaatttcct	acaatttcct	NN	B-NP
gatgcggtat	gatgcggtat	NN	B-NP
2820	2820	FW	0
tttctcctta	tttctcctta	NN	B-NP
cgcatctgtg	cgcatctgtg	NN	B-NP
cggtatttca	cggtatttca	NN	B-NP
caccgcatca	caccgcatca	NN	B-NP
ggtggcactt	ggtggcactt	NN	B-NP
ttcggggaaa	ttcggggaaa	NN	B-NP
2880	2880	FW	0
tgtgcgcgga	tgtgcgcgga	NN	B-NP
acccctattt	acccctattt	NN	B-NP
gtttattttt	gtttattttt	NN	B-NP
ctaaatacat	ctaaatacat	NN	B-NP
tcaaatatgt	tcaaatatgt	NN	B-NP
atccgctcat	atccgctcat	NN	B-NP
2940	2940	FW	0
gagacaataa	gagacaataa	NN	B-NP
ccctgataaa	ccctgataaa	NN	B-NP
tgcttcaata	tgcttcaata	NN	B-NP
atagcacgtg	atagcacgtg	NN	B-NP
ctaaaacttc	ctaaaacttc	NN	B-NP
atttttaatt	atttttaatt	NN	B-NP
3000	3000	FW	0
taaaaggatc	taaaaggatc	NN	B-NP
taggtgaaga	taggtgaaga	NN	B-NP
tcctttttga	tcctttttga	NN	B-NP
taatctccgg	taatctccgg	NN	B-NP
aagagtcaag	aagagtcaag	NN	B-NP
aacatgtgag	aacatgtgag	NN	B-NP
3060	3060	FW	0
caaaaggcca	caaaaggcca	NN	B-NP
gcaaaaggcc	gcaaaaggcc	NN	B-NP
aggaaccgta	aggaaccgta	NN	B-NP
aaaaggccgc	aaaaggccgc	NN	B-NP
gttgctggcg	gttgctggcg	NN	B-NP
tttttccata	tttttccata	NN	B-NP
3120	3120	FW	0
ggctccgccc	ggctccgccc	NN	B-NP
ccctgacgag	ccctgacgag	NN	B-NP
catcacaaaa	catcacaaaa	NN	B-NP
atcgacgctc	atcgacgctc	NN	B-NP
aagtcagagg	aagtcagagg	NN	B-NP
tggcgaaacc	tggcgaaacc	NN	B-NP
3180	3180	FW	0
cgacaggact	cgacaggact	NN	B-NP
ataaagatac	ataaagatac	NN	B-NP
caggcgtttc	caggcgtttc	NN	B-NP
cccctggaag	cccctggaag	NN	B-NP
ctccctcgtg	ctccctcgtg	NN	B-NP
cgctctcctg	cgctctcctg	NN	B-NP
3240	3240	FW	0
ttccgaccct	ttccgaccct	NN	B-NP
gccgcttacc	gccgcttacc	NN	B-NP
ggatacctgt	ggatacctgt	NN	B-NP
ccgcctttct	ccgcctttct	NN	B-NP
cccttcggga	cccttcggga	NN	B-NP
agcgtggcgc	agcgtggcgc	NN	B-NP
3300	3300	FW	0
tttctcatag	tttctcatag	NN	B-NP
ctcacgctgt	ctcacgctgt	NN	B-NP
aggtatctca	aggtatctca	NN	B-NP
gttcggtgta	gttcggtgta	NN	B-NP
ggtcgttcgc	ggtcgttcgc	NN	B-NP
tccaagctgg	tccaagctgg	NN	B-NP
3360	3360	FW	0
gctgtgtgca	gctgtgtgca	NN	B-NP
cgaacccccc	cgaacccccc	NN	B-NP
gttcagcccg	gttcagcccg	NN	B-NP
accgctgcgc	accgctgcgc	NN	B-NP
cttatccggt	cttatccggt	NN	B-NP
aactatcgtc	aactatcgtc	NN	B-NP
3420	3420	FW	0
ttgagtccaa	ttgagtccaa	NN	B-NP
cccggtaaga	cccggtaaga	NN	B-NP
cacgacttat	cacgacttat	NN	B-NP
cgccactggc	cgccactggc	NN	B-NP
agcagccact	agcagccact	NN	B-NP
ggtaacagga	ggtaacagga	NN	B-NP
3480	3480	FW	0
ttagcagagc	ttagcagagc	NN	B-NP
gaggtatgta	gaggtatgta	NN	B-NP
ggcggtgcta	ggcggtgcta	NN	B-NP
cagagttctt	cagagttctt	NN	B-NP
gaagtggtgg	gaagtggtgg	NN	B-NP
cctaactacg	cctaactacg	NN	B-NP
3540	3540	FW	0
gctacactag	gctacactag	NN	B-NP
aagaacagta	aagaacagta	NN	B-NP
tttggtatct	tttggtatct	NN	B-NP
gcgctctgct	gcgctctgct	NN	B-NP
gaagccagtt	gaagccagtt	NN	B-NP
accttcggaa	accttcggaa	NN	B-NP
3600	3600	FW	0
aaagagttgg	aaagagttgg	NN	B-NP
tagctcttga	tagctcttga	NN	B-NP
tccggcaaac	tccggcaaac	NN	B-NP
aaaccaccgc	aaaccaccgc	NN	B-NP
tggtagcggt	tggtagcggt	NN	B-NP
ggtttttttg	ggtttttttg	NN	B-NP
3660	3660	FW	0
tttgcaagca	tttgcaagca	NN	B-NP
gcagattacg	gcagattacg	NN	B-NP
cgcagaaaaa	cgcagaaaaa	NN	B-NP
aaggatctca	aaggatctca	NN	B-NP
agaagatcct	agaagatcct	NN	B-NP
ttgatctttt	ttgatctttt	NN	B-NP
3720	3720	FW	0
ctacggggtc	ctacggggtc	NN	B-NP
tgacgctcag	tgacgctcag	NN	B-NP
tggaacgaaa	tggaacgaaa	NN	B-NP
actcacgtta	actcacgtta	NN	B-NP
agggattttg	agggattttg	NN	B-NP
gtccggccgg	gtccggccgg	NN	B-NP
3780	3780	FW	0
aaacgtttgg	aaacgtttgg	NN	B-NP
ttgctgacta	ttgctgacta	NN	B-NP
attgagatgc	attgagatgc	NN	B-NP
atgctttgca	atgctttgca	NN	B-NP
tacttctgcc	tacttctgcc	NN	B-NP
tgctggggag	tgctggggag	NN	B-NP
3840	3840	FW	0
cctggggact	cctggggact	NN	B-NP
ttccacacct	ttccacacct	NN	B-NP
cgcgatgtac	cgcgatgtac	NN	B-NP
gggccagata	gggccagata	NN	B-NP
tacg	tacg	FW	0
3884	3884	FW	0
US	US	NNP	0
20070003564	20070003564	CD	0
A1	A1	CD	0
20070104	20070104	CD	0
US	US	NNP	0
11473941	11473941	CD	0
20060623	20060623	CD	0
11	11	CD	0
20060101	20060101	CD	0
A	A	DT	0
A	A	NNP	0
61	61	CD	0
K	K	NNP	0
39	39	CD	0
00	00	CD	0
F	F	NN	0
I	I	PRP	0
20070104	20070104	CD	0
US	US	NNP	0
B	B	NNP	B-NP
H	H	NNP	I-NP
20060101	20060101	CD	0
A	A	DT	0
A	A	NNP	0
61	61	CD	0
K	K	NNP	0
38	38	CD	0
17	17	CD	0
L	L	NNP	0
I	I	NNP	0
20070104	20070104	CD	0
US	US	NNP	0
B	B	NNP	B-NP
H	H	NNP	I-NP
20060101	20060101	CD	0
A	A	DT	0
A	A	NNP	0
61	61	CD	0
K	K	NNP	0
31	31	CD	0
7012	7012	CD	0
L	L	NNP	0
I	I	NNP	0
20070104	20070104	CD	0
US	US	NNP	0
B	B	NNP	B-NP
H	H	NNP	I-NP
20060101	20060101	CD	0
A	A	DT	0
A	A	NNP	0
61	61	CD	0
K	K	NNP	0
31	31	CD	0
045	045	CD	0
L	L	NNP	0
I	I	NNP	0
20070104	20070104	CD	0
US	US	NNP	0
B	B	NNP	B-NP
H	H	NNP	I-NP
US	US	NNP	0
424184100	424184100	CD	0
514002000	514002000	CD	0
514053000	514053000	CD	0
514738000	514738000	CD	0
Diluent	Diluent	NN	B-NP
for	for	IN	0
immunohistochemistry	immunohistochemistry	JJ	0
US	US	NNP	0
60696026	60696026	CD	0
20050630	20050630	CD	0
Hurley	Hurley	NNP	B-NP
John	John	NNP	I-NP
K	K	NNP	I-NP
.	.	.	I-NP
Tucson	Tucson	NNP	B-NP
AZ	AZ	NNP	I-NP
US	US	NNP	0
Tucson	Tucson	NNP	B-NP
AZ	AZ	NNP	I-NP
US	US	NNP	0
1910	1910	CD	0
INNOVATION	INNOVATION	NNP	B-NP
PARK	PARK	NNP	I-NP
DRIVE	DRIVE	NNP	I-NP
TUCSON	TUCSON	NNP	I-NP
AZ	AZ	NNP	I-NP
85755	85755	CD	0
US	US	NNP	0
An	An	DT	0
embodiment	embodiment	NN	0
of	of	IN	0
the	the	DT	0
invention	invention	NN	0
is	is	VBZ	0
directed	directed	VBN	0
to	to	TO	0
a	a	DT	0
method	method	NN	0
and	and	CC	0
stabilizing	stabilizing	VBG	B-NP
biomolecule	biomolecule	NN	I-NP
diluent	diluent	NN	I-NP
,	,	,	0
comprising	comprising	VBG	B-NP
tri	tri	NNP	I-NP
and	and	CC	0
a	a	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
selected	selected	VBN	0
from	from	IN	0
the	the	DT	0
group	group	NN	0
consisting	consisting	VBG	0
of	of	IN	0
mannitol	mannitol	NN	B-NP
and	and	CC	0
trehalose	trehalose	NN	B-NP
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
may	may	MD	0
optionally	optionally	RB	0
include	include	VBP	0
casein	casein	VBN	B-NP
added	added	VBN	0
as	as	IN	0
a	a	DT	0
background	background	NN	0
blocking	blocking	VBG	B-NP
protein	protein	NN	I-NP
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
may	may	MD	0
optionally	optionally	RB	0
include	include	VB	0
sodium	sodium	JJ	B-NP
azide	azide	NN	I-NP
as	as	IN	0
an	an	DT	0
anti-microbial	anti-microbial	JJ	B-NP
agent	agent	NN	I-NP
.	.	.	0
Mannitol	Mannitol	NNP	B-NP
and	and	CC	0
/	/	NNP	0
or	or	CC	0
trehalosa	trehalosa	NN	B-NP
are	are	VBP	0
particularly	particularly	RB	0
useful	useful	JJ	0
embodiments	embodiments	NN	0
of	of	IN	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
.	.	.	0
This	This	DT	0
application	application	NN	0
claims	claims	NNS	0
priority	priority	NN	0
to	to	TO	0
U.S.	U.S.	NNP	0
Provisional	Provisional	NNP	0
patent	patent	NN	0
application	application	NN	0
Ser	Ser	NNP	0
.	.	.	0
No.	No.	NNP	0
60	60	CD	0
/	/	CD	0
696,026	696,026	CD	0
filed	filed	VBD	0
06	06	CD	0
/	/	CD	0
30	30	CD	0
/	/	CD	0
2005	2005	CD	0
,	,	,	0
the	the	DT	0
entire	entire	JJ	0
contents	contents	NNS	0
of	of	IN	0
which	which	WDT	0
are	are	VBP	0
incorporated	incorporated	VBN	0
by	by	IN	0
reference	reference	NN	0
herein	herein	NN	0
.	.	.	0
1	1	LS	0
.	.	.	0
Field	Field	NN	0
of	of	IN	0
the	the	DT	0
Invention	Invention	NNPS	0
The	The	DT	0
invention	invention	NN	0
relates	relates	VBZ	0
generally	generally	RB	0
to	to	TO	0
the	the	DT	0
field	field	NN	0
of	of	IN	0
life	life	NN	B-NP
science	science	NN	I-NP
,	,	,	0
more	more	RBR	0
particularly	particularly	RB	0
the	the	DT	0
field	field	NN	0
of	of	IN	0
preservation	preservation	NN	B-NP
and	and	CC	0
storage	storage	NN	0
of	of	IN	0
proteins	proteins	NNS	0
,	,	,	0
and	and	CC	0
further	further	JJ	0
to	to	TO	0
the	the	DT	0
field	field	NN	0
of	of	IN	0
stabilizing	stabilizing	VBG	B-NP
biomolecule	biomolecule	NN	I-NP
for	for	IN	0
subsequent	subsequent	JJ	0
shipping	shipping	NN	0
and	and	CC	0
storage	storage	NN	0
for	for	IN	0
later	later	JJ	0
use	use	NN	0
in	in	IN	0
Immunohistochemistry	Immunohistochemistry	NNP	B-NP
(	(	-LRB-	0
immunohistochemistry	immunohistochemistry	NN	B-NP
)	)	-RRB-	0
.	.	.	0
2	2	LS	0
.	.	.	0
Description	Description	NN	0
of	of	IN	0
Related	Related	NNP	0
Art	Art	NNP	0
buffered	buffered	NN	B-NP
protein	protein	NN	I-NP
solution	solution	NN	I-NP
have	have	VBP	0
long	long	RB	0
been	been	VBN	0
used	used	VBN	0
as	as	IN	0
diluent	diluent	NN	B-NP
,	,	,	0
or	or	CC	0
stabilizing	stabilizing	VBG	0
buffered	buffered	JJ	B-NP
solution	solution	NN	I-NP
,	,	,	0
for	for	IN	0
storage	storage	NN	0
and	and	CC	0
dilution	dilution	NN	0
of	of	IN	0
active	active	JJ	0
biomolecules	biomolecules	JJ	0
such	such	JJ	0
as	as	IN	0
for	for	IN	0
example	example	NN	B-NP
antibody	antibody	NN	I-NP
.	.	.	0
diluent	diluent	NN	B-NP
also	also	RB	0
serve	serve	VB	0
the	the	DT	0
function	function	NN	0
of	of	IN	0
reducing	reducing	VBG	B-NP
non-specific	non-specific	JJ	I-NP
binding	binding	NN	I-NP
to	to	TO	0
containers	containers	VB	0
they	they	PRP	0
are	are	VBP	0
in	in	IN	0
,	,	,	0
and	and	CC	0
to	to	TO	0
tissue	tissue	NN	0
components	components	NNS	0
they	they	PRP	0
may	may	MD	0
later	later	RB	0
contact	contact	VB	0
in	in	IN	0
normal	normal	JJ	B-NP
analytical	analytical	JJ	I-NP
use	use	NN	I-NP
.	.	.	0
Sugars	Sugars	JJ	0
such	such	JJ	0
as	as	IN	0
Sorbitol	Sorbitol	NNP	B-NP
(	(	-LRB-	0
Andersson	Andersson	NNP	0
,	,	,	0
Maria	Maria	NNP	0
,	,	,	0
Protein	Protein	NNP	B-NP
Stabilization	Stabilization	NNP	I-NP
.	.	.	0
Some	Some	DT	0
Methods	Methods	NNP	0
and	and	CC	0
Mechanisms	Mechanisms	NNP	0
,	,	,	0
Dissertation	Dissertation	NNP	B-NP
abstract	abstract	NN	I-NP
,	,	,	0
Lund	Lund	NNP	0
University	University	NNP	0
,	,	,	0
1999	1999	CD	0
,	,	,	0
http://theses.lub.lu.se/postgrad/	http://theses.lub.lu.se/postgrad/	CD	0
)	)	-RRB-	0
have	have	VBP	0
been	been	VBN	0
used	used	VBN	0
historically	historically	RB	0
to	to	TO	0
improve	improve	VB	0
the	the	DT	0
stability	stability	NN	0
of	of	IN	0
proteins	proteins	NNS	0
during	during	IN	0
and	and	CC	0
after	after	IN	0
the	the	DT	0
lyophilization	lyophilization	JJ	B-NP
process	process	NN	I-NP
(	(	-LRB-	0
essentially	essentially	RB	0
freeze-drying	freeze-drying	JJ	0
)	)	-RRB-	0
to	to	TO	0
improve	improve	VB	0
their	their	PRP$	0
shelf-life	shelf-life	JJ	B-NP
.	.	.	0
lyophilized	lyophilized	NN	B-NP
antibody	antibody	NN	I-NP
generally	generally	RB	0
have	have	VBP	0
much	much	RB	0
longer	longer	RBR	0
shelf-life	shelf-life	NN	B-NP
,	,	,	0
and	and	CC	0
in	in	IN	0
some	some	DT	0
cases	cases	NNS	0
may	may	MD	0
be	be	VB	0
stored	stored	VBN	0
indefinitely	indefinitely	RB	0
if	if	IN	0
kept	kept	VBN	0
in	in	IN	0
a	a	DT	0
low-temperature	low-temperature	JJ	B-NP
environment	environment	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
antibody	antibody	NN	B-NP
stored	stored	VBD	0
in	in	IN	0
diluents	diluents	VBG	0
still	still	RB	0
do	do	VBP	0
not	not	RB	0
match	match	VB	0
the	the	DT	0
shelf	shelf	NN	0
life	life	NN	0
of	of	IN	0
a	a	DT	0
lyophilized	lyophilized	JJ	B-NP
antibody	antibody	NN	I-NP
,	,	,	0
so	so	RB	0
improved	improved	JJ	0
diluent	diluent	NN	B-NP
are	are	VBP	0
still	still	RB	0
needed	needed	VBN	0
.	.	.	0
numerous	numerous	JJ	B-NP
publication	publication	NN	I-NP
in	in	IN	0
the	the	DT	0
art	art	NN	0
disclose	disclose	NN	0
means	means	VBZ	0
of	of	IN	0
increasing	increasing	VBG	0
the	the	DT	0
stability	stability	NN	0
of	of	IN	0
a	a	DT	0
lyophilized	lyophilized	JJ	B-NP
reagent	reagent	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
difficulties	difficulties	NNS	0
inherent	inherent	VBP	0
even	even	RB	0
within	within	IN	0
this	this	DT	0
state-of-the-art	state-of-the-art	JJ	B-NP
technology	technology	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
U.S.	U.S.	NNP	0
Pat	Pat	NNP	0
.	.	.	0
Nos.	Nos.	NNP	0
5,955,448	5,955,448	NNP	0
,	,	,	0
4,496,537	4,496,537	NNP	0
,	,	,	0
and	and	CC	0
PCT	PCT	NNP	0
filing	filing	NN	0
WO	WO	NNP	0
97	97	CD	0
/	/	CD	0
04801	04801	CD	0
all	all	DT	0
disclose	disclose	JJ	0
improvement	improvement	NN	B-NP
in	in	IN	0
lyophilization	lyophilization	JJ	B-NP
technique	technique	NN	I-NP
.	.	.	0
Lyophilization	Lyophilization	NNP	B-NP
of	of	IN	0
protein-containing	protein-containing	JJ	0
solutions	solutions	NNS	0
,	,	,	0
however	however	RB	0
,	,	,	0
imposes	imposes	VBZ	0
major	major	JJ	0
costs	costs	NNS	0
and	and	CC	0
inconvenience	inconvenience	NN	B-NP
on	on	IN	0
the	the	DT	0
manufacturer	manufacturer	NN	B-NP
and	and	CC	0
the	the	DT	0
end	end	NN	B-NP
user	user	NN	I-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
introducing	introducing	VBG	0
an	an	DT	0
increased	increased	JJ	0
risk	risk	NN	0
of	of	IN	0
reconstitution	reconstitution	JJ	B-NP
error	error	NN	I-NP
and	and	CC	0
contamination	contamination	NN	B-NP
.	.	.	0
Additionally	Additionally	RB	0
,	,	,	0
freeze-drying	freeze-drying	JJ	0
of	of	IN	0
a	a	DT	0
solution	solution	NN	B-NP
requires	requires	VBZ	0
special	special	JJ	0
equipment	equipment	NN	B-NP
and	and	CC	0
ultimately	ultimately	RB	0
can	can	MD	0
lead	lead	VB	0
to	to	TO	0
protein	protein	VB	B-NP
degradation	degradation	VBN	I-NP
when	when	WRB	0
repeated	repeated	JJ	0
cycling	cycling	NN	0
occurs	occurs	VBZ	0
.	.	.	0
For	For	IN	0
commercial	commercial	JJ	B-NP
use	use	NN	I-NP
,	,	,	0
polypeptide	polypeptide	NN	B-NP
deterioration	deterioration	NN	I-NP
and	and	CC	0
antigen	antigen	NN	B-NP
in	in	IN	0
aqueous	aqueous	JJ	B-NP
solution	solution	NN	I-NP
is	is	VBZ	0
costly	costly	JJ	0
because	because	IN	0
such	such	JJ	0
solutions	solutions	NNS	0
require	require	VBP	0
replacement	replacement	NN	0
after	after	IN	0
only	only	RB	0
a	a	DT	0
short	short	JJ	0
storage	storage	NN	B-NP
life	life	NN	I-NP
.	.	.	0
PCT	PCT	NNP	0
pub	pub	NN	B-NP
.	.	.	0
No	No	UH	0
.	.	.	0
WO99	WO99	CD	B-NP
/	/	CD	0
15901	15901	CD	0
discloses	discloses	VBZ	0
a	a	DT	0
antigen	antigen	NN	B-NP
stabilization	stabilization	NN	I-NP
diluent	diluent	NN	I-NP
,	,	,	0
in	in	IN	0
particular	particular	JJ	0
,	,	,	0
Hepatitis	Hepatitis	NNP	B-NP
C	C	NNP	I-NP
Virus	Virus	NNP	I-NP
(	(	-LRB-	0
HCV	HCV	NNP	B-NP
)	)	-RRB-	0
antigen	antigen	NN	B-NP
.	.	.	0
The	The	DT	0
HCV	HCV	NNP	B-NP
diluent	diluent	NN	I-NP
comprises	comprises	VBZ	0
a	a	DT	0
reducing	reducing	VBG	B-NP
agent	agent	NN	I-NP
to	to	TO	0
keep	keep	VB	0
the	the	DT	0
hcv	hcv	NN	B-NP
antigen	antigen	NN	I-NP
in	in	IN	0
a	a	DT	0
reduced	reduced	JJ	0
form	form	NN	0
.	.	.	0
The	The	DT	0
publication	publication	NN	0
reports	reports	NNS	0
that	that	IN	0
the	the	DT	0
inclusion	inclusion	NN	0
of	of	IN	0
a	a	DT	0
reducing	reducing	VBG	B-NP
agent	agent	NN	I-NP
in	in	IN	0
a	a	DT	0
diluent	diluent	NN	B-NP
maintained	maintained	VBD	0
the	the	DT	0
immunoreactivity	immunoreactivity	NN	B-NP
of	of	IN	0
an	an	DT	0
HCV	HCV	NNP	B-NP
antigen	antigen	NN	I-NP
for	for	IN	0
up	up	RB	0
to	to	TO	0
seven	seven	CD	0
days	days	NNS	0
.	.	.	0
The	The	DT	0
reported	reported	JJ	0
diluent	diluent	NN	B-NP
further	further	RBR	0
comprises	comprises	JJ	0
sodium	sodium	JJ	B-NP
phosphate	phosphate	NN	I-NP
,	,	,	0
pH	pH	JJ	0
6.5	6.5	CD	0
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
buffer	buffer	NN	B-NP
)	)	-RRB-	0
,	,	,	0
EDTA	EDTA	NNP	B-NP
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
chelator	chelator	NN	B-NP
)	)	-RRB-	0
,	,	,	0
DTT	DTT	NNP	B-NP
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
reducing	reducing	VBG	B-NP
agent	agent	NN	I-NP
)	)	-RRB-	0
,	,	,	0
gelatin	gelatin	NN	B-NP
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
blocking	blocking	VBG	B-NP
source	source	NN	I-NP
protein	protein	NN	I-NP
)	)	-RRB-	0
,	,	,	0
ammonium	ammonium	NN	B-NP
thiocyanate	thiocyanate	NN	I-NP
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
chaotrope	chaotrope	NN	B-NP
)	)	-RRB-	0
,	,	,	0
sodium	sodium	NN	B-NP
azide	azide	NN	I-NP
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
preservative	preservative	NN	B-NP
)	)	-RRB-	0
and	and	CC	0
sd	sd	NN	B-NP
(	(	-LRB-	0
or	or	CC	0
other	other	JJ	0
detergent	detergent	NN	B-NP
)	)	-RRB-	0
.	.	.	0
U.S.	U.S.	NNP	0
Pat	Pat	NNP	0
.	.	.	0
No.	No.	NNP	0
4,956,274	4,956,274	NNP	0
concerns	concerns	NNS	0
techniques	techniques	NNS	0
for	for	IN	0
stabilizing	stabilizing	VBG	0
peptide	peptide	JJ	B-NP
fragment	fragment	NN	I-NP
from	from	IN	0
beta-galactosidase	beta-galactosidase	JJ	B-NP
for	for	IN	0
use	use	NN	0
in	in	IN	0
complementation	complementation	JJ	B-NP
assay	assay	NN	I-NP
.	.	.	0
The	The	DT	0
solution	solution	NN	B-NP
disclosed	disclosed	VBN	0
in	in	IN	0
U.S.	U.S.	NNP	0
Pat	Pat	NNP	0
.	.	.	0
No.	No.	NNP	0
4,956,274	4,956,274	NNP	0
contained	contained	VBD	0
an	an	DT	0
ionic	ionic	JJ	B-NP
surfactant	surfactant	NN	I-NP
or	or	CC	0
a	a	DT	0
surfactant	surfactant	NN	B-NP
derived	derived	VBN	0
from	from	IN	0
a	a	DT	0
sugar	sugar	NN	B-NP
residue	residue	NN	I-NP
to	to	TO	0
slow	slow	VB	0
degradation	degradation	VBN	0
of	of	IN	0
peptide	peptide	JJ	B-NP
fragment	fragment	NN	I-NP
beta-galactosidase	beta-galactosidase	JJ	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
surfactant	surfactant	NN	B-NP
also	also	RB	0
denatured	denatured	VB	0
the	the	DT	0
enzyme	enzyme	JJ	0
fragments	fragments	NNS	0
,	,	,	0
and	and	CC	0
thus	thus	RB	0
had	had	VBD	0
to	to	TO	0
be	be	VB	0
removed	removed	VBN	0
or	or	CC	0
neutralized	neutralized	JJ	0
to	to	TO	0
enable	enable	VB	0
the	the	DT	0
enzymatic	enzymatic	JJ	B-NP
fragment	fragment	NN	I-NP
to	to	TO	0
return	return	VB	0
to	to	TO	0
their	their	PRP$	0
correct	correct	JJ	0
conformation	conformation	NN	B-NP
and	and	CC	0
regain	regain	VB	0
enzymatic	enzymatic	JJ	B-NP
activity	activity	NN	I-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
the	the	DT	0
solution	solution	NN	B-NP
did	did	VBD	0
not	not	RB	0
stabilize	stabilize	VB	0
the	the	DT	0
native	native	JJ	0
form	form	NN	0
of	of	IN	0
the	the	DT	0
protein	protein	NN	B-NP
.	.	.	0
The	The	DT	0
surfactant	surfactant	NN	B-NP
are	are	VBP	0
neutralized	neutralized	VBN	0
just	just	RB	0
prior	prior	RB	0
to	to	TO	0
the	the	DT	0
assay	assay	NN	B-NP
by	by	IN	0
using	using	VBG	0
cyclodextrin	cyclodextrin	NN	B-NP
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
the	the	DT	0
action	action	NN	0
of	of	IN	0
the	the	DT	0
surfactant	surfactant	NN	B-NP
was	was	VBD	0
masked	masked	VBN	0
with	with	IN	0
a	a	DT	0
high	high	JJ	0
serum	serum	NN	B-NP
concentration	concentration	NN	I-NP
.	.	.	0
Additional	Additional	JJ	0
components	components	NNS	0
of	of	IN	0
the	the	DT	0
disclosed	disclosed	VBN	B-NP
reagent	reagent	NN	I-NP
included	included	VBD	0
a	a	DT	0
chelating	chelating	JJ	B-NP
agent	agent	NN	I-NP
,	,	,	0
buffer	buffer	NN	B-NP
,	,	,	0
bacteriocide	bacteriocide	NN	B-NP
,	,	,	0
magnesium	magnesium	NN	B-NP
or	or	CC	0
other	other	JJ	0
ions	ions	NN	0
,	,	,	0
reducing	reducing	VBG	B-NP
agent	agent	NN	I-NP
,	,	,	0
solubilizing	solubilizing	JJ	B-NP
agent	agent	NN	I-NP
such	such	JJ	0
as	as	IN	0
solvents	solvents	NNS	0
like	like	IN	0
ethylene	ethylene	NN	0
glycol	glycol	NN	0
,	,	,	0
and	and	CC	0
nonionic	nonionic	JJ	B-NP
detergent	detergent	JJ	I-NP
.	.	.	0
As	As	IN	0
those	those	DT	0
in	in	IN	0
the	the	DT	0
art	art	NN	0
will	will	MD	0
appreciate	appreciate	VB	0
denaturing	denaturing	NN	B-NP
and	and	CC	0
renaturing	renaturing	JJ	B-NP
protein	protein	NN	I-NP
or	or	CC	0
enzyme	enzyme	JJ	0
fragments	fragments	NNS	0
may	may	MD	0
damage	damage	VB	0
some	some	DT	0
antigenic	antigenic	JJ	B-NP
epitope	epitope	NN	I-NP
and	and	CC	0
render	render	VBD	0
them	them	PRP	0
inactive	inactive	VBD	0
.	.	.	0
Landi	Landi	NNP	0
,	,	,	0
S.	S.	NNP	0
and	and	CC	0
Held	Held	NNP	0
,	,	,	0
H.	H.	NNP	B-NP
R.	R.	NNP	I-NP
(	(	-LRB-	0
Tubercle	Tubercle	NNP	B-NP
59	59	CD	0
(	(	-LRB-	0
1978	1978	CD	0
)	)	-RRB-	0
121-133	121-133	CD	0
)	)	-RRB-	0
reported	reported	VBD	0
the	the	DT	0
tween	tween	NN	B-NP
addition	addition	NN	I-NP
20	20	CD	0
(	(	-LRB-	0
Polyoxyethylene	Polyoxyethylene	NNP	B-NP
Sorbitan	Sorbitan	NNP	I-NP
Monooleate	Monooleate	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
detergent	detergent	NN	B-NP
into	into	IN	0
a	a	DT	0
diluted	diluted	JJ	0
solution	solution	NN	B-NP
and	and	CC	0
suggested	suggested	VBD	0
that	that	DT	0
tuberculin	tuberculin	JJ	B-NP
PPD	PPD	NNP	I-NP
stability	stability	NN	I-NP
was	was	VBD	0
enhanced	enhanced	VBN	0
by	by	IN	0
this	this	DT	0
addition	addition	NN	B-NP
due	due	JJ	0
to	to	TO	0
the	the	DT	0
detergent	detergent	NN	0
's	's	POS	0
anti-adsorptive	anti-adsorptive	JJ	B-NP
property	property	NN	I-NP
.	.	.	0
The	The	DT	0
tuberculin	tuberculin	JJ	B-NP
preparation	preparation	NN	I-NP
,	,	,	0
made	made	VBN	0
by	by	IN	0
Connaught	Connaught	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
LTD.	LTD.	NNP	0
,	,	,	0
contains	contains	VBZ	0
tuberculin	tuberculin	JJ	B-NP
PPD	PPD	NNP	I-NP
,	,	,	0
0.3	0.3	CD	0
%	%	NN	0
phenol	phenol	NN	B-NP
(	(	-LRB-	0
reported	reported	VBN	0
to	to	TO	0
act	act	VB	0
as	as	IN	0
a	a	DT	0
preservative	preservative	NN	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
0.0005	0.0005	CD	0
%	%	NN	0
TWEEN	TWEEN	NNP	B-NP
80	80	CD	0
(	(	-LRB-	0
Polyoxyethylene	Polyoxyethylene	NNP	B-NP
Sorbitan	Sorbitan	NNP	I-NP
Monooleate	Monooleate	NNP	I-NP
)	)	-RRB-	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
.	.	.	0
U.S.	U.S.	NNP	0
Pat	Pat	NNP	0
.	.	.	0
No.	No.	NNP	0
6,579,688	6,579,688	NNP	0
(	(	-LRB-	0
Steaffen	Steaffen	NN	B-NP
et	et	FW	0
al.	al.	FW	0
)	)	-RRB-	0
discloses	discloses	VBZ	0
a	a	DT	0
diluent	diluent	JJ	B-NP
useful	useful	JJ	I-NP
for	for	IN	0
stabilizing	stabilizing	VBG	0
antigens	antigens	JJ	B-NP
useful	useful	JJ	I-NP
in	in	IN	0
analytical	analytical	JJ	B-NP
procedure	procedure	NN	I-NP
comprising	comprising	VBG	0
50	50	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
phosphate	phosphate	NN	I-NP
,	,	,	0
2	2	CD	0
%	%	NN	0
v	v	NN	B-NP
/	/	NN	I-NP
v	v	NN	I-NP
fetal	fetal	JJ	I-NP
calf	calf	NN	I-NP
serum	serum	NN	I-NP
,	,	,	0
1	1	CD	0
%	%	NN	0
v	v	NN	B-NP
/	/	NN	I-NP
v	v	NN	I-NP
glycerol	glycerol	NN	I-NP
,	,	,	0
50	50	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
chloride	chloride	NN	I-NP
,	,	,	0
5	5	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
0.05	0.05	CD	0
%	%	NN	0
v	v	NN	B-NP
/	/	NN	I-NP
v	v	NN	I-NP
TWEEN	TWEEN	NNP	I-NP
20	20	CD	0
(	(	-LRB-	0
Polyoxyethylene	Polyoxyethylene	NNP	B-NP
Sorbitan	Sorbitan	NNP	I-NP
Monolaurate	Monolaurate	NNP	I-NP
)	)	-RRB-	0
detergent	detergent	NN	B-NP
,	,	,	0
0.01	0.01	CD	0
%	%	NN	0
w	w	NN	B-NP
/	/	NN	I-NP
v	v	NN	I-NP
quaternary	quaternary	NN	I-NP
ammonium	ammonium	NN	I-NP
compound	compound	JJ	I-NP
,	,	,	0
and	and	CC	0
0.5	0.5	CD	0
%	%	NN	0
w	w	NN	B-NP
/	/	NN	I-NP
v	v	NN	I-NP
gentamycin	gentamycin	NN	I-NP
sulfate	sulfate	NN	I-NP
.	.	.	0
An	An	DT	0
embodiment	embodiment	NN	0
of	of	IN	0
the	the	DT	0
invention	invention	NN	0
is	is	VBZ	0
directed	directed	VBN	0
to	to	TO	0
a	a	DT	0
stabilizing	stabilizing	VBG	B-NP
biomolecule	biomolecule	NN	I-NP
diluent	diluent	NN	I-NP
,	,	,	0
comprising	comprising	VBG	B-NP
tri	tri	NNP	I-NP
and	and	CC	0
a	a	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
selected	selected	VBN	0
from	from	IN	0
the	the	DT	0
group	group	NN	0
consisting	consisting	VBG	0
of	of	IN	0
mannitol	mannitol	NN	B-NP
and	and	CC	0
trehalose	trehalose	NN	B-NP
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
may	may	MD	0
optionally	optionally	RB	0
include	include	VBP	0
casein	casein	VBN	B-NP
added	added	VBN	0
as	as	IN	0
a	a	DT	0
background	background	NN	0
blocking	blocking	VBG	B-NP
protein	protein	NN	I-NP
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
may	may	MD	0
optionally	optionally	RB	0
include	include	VB	0
sodium	sodium	JJ	B-NP
azide	azide	NN	I-NP
as	as	IN	0
an	an	DT	0
anti-microbial	anti-microbial	JJ	B-NP
agent	agent	NN	I-NP
.	.	.	0
Mannitol	Mannitol	NNP	B-NP
and	and	CC	0
/	/	NNP	0
or	or	CC	0
trehalosa	trehalosa	NN	B-NP
are	are	VBP	0
particularly	particularly	RB	0
useful	useful	JJ	0
embodiments	embodiments	NN	0
of	of	IN	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
.	.	.	0
Another	Another	DT	0
embodiment	embodiment	NN	0
of	of	IN	0
the	the	DT	0
invention	invention	NN	0
is	is	VBZ	0
a	a	DT	0
method	method	NN	0
for	for	IN	0
stabilizing	stabilizing	VBG	B-NP
biomolecule	biomolecule	NN	I-NP
comprising	comprising	VBP	0
storing	storing	VBG	0
a	a	DT	0
biomolecule	biomolecule	NN	B-NP
in	in	IN	0
a	a	DT	0
comprising	comprising	VBG	B-NP
tri	tri	NNP	I-NP
diluent	diluent	NN	I-NP
and	and	CC	0
a	a	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
selected	selected	VBN	0
from	from	IN	0
the	the	DT	0
group	group	NN	0
consisting	consisting	VBG	0
of	of	IN	0
mannitol	mannitol	NN	B-NP
and	and	CC	0
trehalose	trehalose	NN	B-NP
.	.	.	0
FIG.	FIG.	CD	0
1	1	CD	0
shows	shows	NNS	0
four	four	CD	0
microphotograph	microphotograph	NN	B-NP
of	of	IN	0
tonsil	tonsil	JJ	0
sections	sections	NNS	0
stained	stained	VBN	0
with	with	IN	0
anti-Ki67	anti-Ki67	CD	B-NP
antibody	antibody	NN	I-NP
using	using	VBG	0
QDot	QDot	JJ	0
605-Streptavidin	605-Streptavidin	CD	0
conjugate	conjugate	NN	0
on	on	IN	0
Day	Day	NNP	0
0	0	CD	0
and	and	CC	0
Day	Day	NNP	0
1	1	CD	0
following	following	VBG	0
one	one	CD	0
day	day	NN	0
of	of	IN	0
storage	storage	NN	0
at	at	IN	0
37	37	CD	0
degrees	degrees	NNS	0
diluent	diluent	NN	B-NP
c.	c.	NN	I-NP
md	md	NN	I-NP
is	is	VBZ	0
used	used	VBN	0
on	on	IN	0
the	the	DT	0
left	left	JJ	0
frames	frames	NNS	0
,	,	,	0
while	while	IN	0
casein+0.08	casein+0.08	CD	B-NP
%	%	NN	0
NaN3	NaN3	NN	B-NP
is	is	VBZ	0
used	used	VBN	0
in	in	IN	0
the	the	DT	0
two	two	CD	0
frames	frames	NNS	0
on	on	IN	0
the	the	DT	0
right	right	NN	0
.	.	.	0
FIG.	FIG.	CD	0
2	2	CD	0
shows	shows	NNS	0
four	four	CD	0
anti-cd45	anti-cd45	NN	B-NP
lca	lca	NN	I-NP
staining	staining	NN	I-NP
photomicrograph	photomicrograph	NN	I-NP
of	of	IN	0
tonsil	tonsil	JJ	0
sections	sections	NNS	0
detected	detected	VBD	0
using	using	VBG	0
a	a	DT	0
Qdot	Qdot	NNP	0
605-Streptavidin	605-Streptavidin	NNP	0
conjugate	conjugate	NN	0
.	.	.	0
Comparison	Comparison	NN	0
of	of	IN	0
Casein	Casein	NNP	B-NP
(	(	-LRB-	0
15	15	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
,	,	,	0
0.08	0.08	CD	0
%	%	NN	0
NaN3	NaN3	CD	B-NP
)	)	-RRB-	0
with	with	IN	0
tri	tri	NNP	B-NP
buffered	buffered	FW	0
manitol	manitol	NN	B-NP
containing	containing	FW	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
albumin	albumin	NN	I-NP
,	,	,	0
bovine	bovine	JJ	B-NP
gamma	gamma	JJ	I-NP
globulin	globulin	NN	I-NP
or	or	CC	0
casein	casein	NN	B-NP
.	.	.	0
FIG.	FIG.	CD	0
3	3	CD	0
shows	shows	NNS	0
four	four	CD	0
anti-cd45	anti-cd45	NN	B-NP
lca	lca	NN	I-NP
staining	staining	NN	I-NP
photomicrograph	photomicrograph	NN	I-NP
of	of	IN	0
tonsil	tonsil	JJ	0
sections	sections	NNS	0
detected	detected	VBD	0
using	using	VBG	0
a	a	DT	0
Qdot	Qdot	NNP	0
605-streptavidin	605-streptavidin	NNP	0
conjugate	conjugate	NN	0
.	.	.	0
Comparison	Comparison	NN	0
of	of	IN	0
Casein	Casein	NNP	B-NP
(	(	-LRB-	0
15	15	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
,	,	,	0
0.08	0.08	CD	0
%	%	NN	0
NaN3	NaN3	CD	B-NP
)	)	-RRB-	0
with	with	IN	0
tri	tri	NNP	B-NP
buffered	buffered	FW	0
manitol	manitol	NN	B-NP
containing	containing	FW	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
albumin	albumin	NN	I-NP
,	,	,	0
bovine	bovine	JJ	B-NP
gamma	gamma	JJ	I-NP
globulin	globulin	NN	I-NP
or	or	CC	0
casein	casein	NN	B-NP
.	.	.	0
FIG.	FIG.	CD	0
4	4	CD	0
shows	shows	NNS	0
six	six	CD	0
Tonsil	Tonsil	JJ	0
sections	sections	NNS	0
stained	stained	VBN	0
with	with	IN	0
anti-CD45	anti-CD45	NNP	B-NP
LCA	LCA	NNP	I-NP
diluted	diluted	VBD	0
in	in	IN	0
either	either	DT	0
antibody	antibody	NN	B-NP
diluent	diluent	NNS	I-NP
md	md	NN	I-NP
or	or	CC	0
50	50	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
100	100	CD	0
mM	mM	JJ	B-NP
Manitol	Manitol	NNP	I-NP
,	,	,	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
Casein	Casein	NNP	I-NP
and	and	CC	0
0.08	0.08	CD	0
%	%	NN	0
NaN3	NaN3	NN	B-NP
and	and	CC	0
stored	stored	VBD	0
at	at	IN	0
45	45	CD	0
C	C	NNP	0
.	.	.	0
FIG.	FIG.	CD	0
5	5	CD	0
shows	shows	NNS	0
six	six	CD	0
carcinoma	carcinoma	JJ	B-NP
section	section	NN	I-NP
photomicrograph	photomicrograph	NN	I-NP
stained	stained	VBN	0
with	with	IN	0
anti-pERK	anti-pERK	JJ	B-NP
antibody	antibody	NN	I-NP
diluted	diluted	VBN	0
in	in	IN	0
either	either	DT	0
TBST	TBST	NNP	B-NP
antibody	antibody	NN	I-NP
diluent	diluent	NN	I-NP
or	or	CC	0
50	50	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
100	100	CD	0
mM	mM	JJ	B-NP
Mannitol	Mannitol	NNP	I-NP
,	,	,	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
Casein	Casein	NNP	I-NP
and	and	CC	0
0.08	0.08	CD	0
%	%	NN	0
NaN3	NaN3	NN	B-NP
and	and	CC	0
stored	stored	VBD	0
at	at	IN	0
45	45	CD	0
C	C	NNP	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
the	the	DT	0
present	present	JJ	0
invention	invention	NN	0
comprises	comprises	VBZ	0
a	a	DT	0
Tris	Tris	JJ	B-NP
buffer	buffer	NN	I-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
selected	selected	VBN	0
from	from	IN	0
the	the	DT	0
group	group	NN	0
consisting	consisting	VBG	0
of	of	IN	0
Mannitol	Mannitol	NNP	B-NP
and	and	CC	0
trehalose	trehalose	NN	B-NP
.	.	.	0
Casein	Casein	NNP	B-NP
may	may	MD	0
be	be	VB	0
useful	useful	JJ	0
as	as	IN	0
a	a	DT	0
background	background	NN	B-NP
blocker	blocker	NN	I-NP
for	for	IN	0
subsequent	subsequent	JJ	0
staining	staining	NN	0
runs	runs	VBZ	0
.	.	.	0
Optionally	Optionally	NNP	0
,	,	,	0
a	a	DT	0
preservative	preservative	JJ	B-NP
anti-microbial	anti-microbial	JJ	I-NP
such	such	JJ	0
as	as	IN	0
sodium	sodium	JJ	B-NP
azide	azide	NN	I-NP
may	may	MD	0
be	be	VB	0
used	used	VBN	0
.	.	.	0
The	The	DT	0
preferred	preferred	JJ	0
diluent	diluent	NN	B-NP
is	is	VBZ	0
tri	tri	NNP	B-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.2	7.2	CD	0
)	)	-RRB-	0
,	,	,	0
mannitol	mannitol	NN	B-NP
,	,	,	0
hydrolyzed	hydrolyzed	JJ	B-NP
casein	casein	NN	I-NP
and	and	CC	0
sodium	sodium	JJ	B-NP
azide	azide	NN	I-NP
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
may	may	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
dilute	dilute	VB	0
antibody	antibody	NN	B-NP
or	or	CC	0
other	other	JJ	0
biomolecule	biomolecule	NN	B-NP
for	for	IN	0
shipment	shipment	NN	0
and	and	CC	0
/	/	NNP	0
or	or	CC	0
storage	storage	NN	0
.	.	.	0
Trizma	Trizma	JJ	B-NP
base	base	NN	I-NP
(	(	-LRB-	I-NP
Tris	Tris	NNP	I-NP
(	(	-LRB-	I-NP
hydroxymethyl	hydroxymethyl	LS	I-NP
)	)	-RRB-	I-NP
aminomethane	aminomethane	NN	I-NP
)	)	-RRB-	0
is	is	VBZ	0
the	the	DT	0
preferred	preferred	JJ	0
buffer	buffer	NN	B-NP
for	for	IN	0
this	this	DT	0
diluent	diluent	NN	B-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
available	available	JJ	0
from	from	IN	0
many	many	JJ	0
suppliers	suppliers	NNS	0
but	but	CC	0
one	one	PRP	0
is	is	VBZ	0
Sigma-Aldrich	Sigma-Aldrich	JJ	B-NP
(	(	-LRB-	0
St.	St.	NNP	B-NP
Louis	Louis	NNP	0
,	,	,	0
Mo	Mo	NNP	0
.	.	.	0
)	)	-RRB-	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
T6066	T6066	NNP	0
.	.	.	0
Although	Although	IN	0
it	it	PRP	0
may	may	MD	0
be	be	VB	0
useful	useful	JJ	0
in	in	IN	0
a	a	DT	0
range	range	NN	0
of	of	IN	0
concentration	concentration	NN	B-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
most	most	RBS	0
preferred	preferred	VBN	0
at	at	IN	0
0.05	0.05	CD	0
molar	molar	NN	B-NP
(	(	-LRB-	0
50	50	CD	0
mmol	mmol	CD	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
physiological	physiological	JJ	B-NP
pH	pH	NN	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
6.8-7.8	6.8-7.8	NNP	0
)	)	-RRB-	0
.	.	.	0
pH	pH	SYM	B-NP
7.2	7.2	CD	0
is	is	VBZ	0
preferred.	preferred.	NNP	0
pH	pH	NNP	B-NP
is	is	VBZ	0
adjusted	adjusted	VBN	0
simply	simply	RB	0
by	by	IN	0
adding	adding	VBG	0
concentrated	concentrated	JJ	0
HCl	HCl	NN	B-NP
until	until	IN	0
the	the	DT	0
desired	desired	JJ	0
pH	pH	NN	B-NP
is	is	VBZ	0
attained	attained	VBN	0
.	.	.	0
A	A	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
is	is	VBZ	0
an	an	DT	0
organic	organic	JJ	B-NP
compound	compound	NN	I-NP
consisting	consisting	VBG	0
of	of	IN	0
a	a	DT	0
chain	chain	NN	0
of	of	IN	0
carbon	carbon	NN	0
atoms	atoms	NNS	0
to	to	TO	0
which	which	WDT	0
hydrogen	hydrogen	NN	B-NP
and	and	CC	0
oxygen	oxygen	NN	B-NP
are	are	VBP	0
attached	attached	VBN	0
in	in	IN	0
a	a	DT	0
2	2	CD	0
:	:	:	0
1	1	CD	0
ratio	ratio	NN	0
,	,	,	0
eg	eg	NN	B-NP
,	,	,	0
sugars	sugars	NN	0
,	,	,	0
starch	starch	NN	B-NP
,	,	,	0
glycogen	glycogen	NN	B-NP
,	,	,	0
cellulose	cellulose	NN	B-NP
,	,	,	0
and	and	CC	0
that	that	WDT	0
contain	contain	VBP	0
multiple	multiple	JJ	0
hydroxy	hydroxy	NN	B-NP
(	(	-LRB-	0
OH	OH	NNP	B-NP
)	)	-RRB-	0
groups	groups	NNS	0
.	.	.	0
D-Mannitol	D-Mannitol	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
sugar	sugar	NN	B-NP
alcohol	alcohol	NN	I-NP
,	,	,	0
available	available	JJ	0
from	from	IN	0
Sigma-Aldrich	Sigma-Aldrich	NNP	B-NP
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
M9647	M9647	NNP	0
.	.	.	0
The	The	DT	0
concentration	concentration	NN	B-NP
range	range	NN	I-NP
is	is	VBZ	0
from	from	IN	0
about	about	IN	0
100	100	CD	0
to	to	TO	0
about	about	RB	0
400	400	CD	0
mmol	mmol	NN	B-NP
,	,	,	0
and	and	CC	0
most	most	RBS	0
preferred	preferred	JJ	0
is	is	VBZ	0
100	100	CD	0
mmol	mmol	NN	B-NP
.	.	.	0
Trehalose	Trehalose	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
naturally	naturally	RB	0
occurring	occurring	VBG	B-NP
disacharrida	disacharrida	NN	I-NP
composed	composed	VBN	0
of	of	IN	0
two	two	CD	0
d-glucopyranose	d-glucopyranose	NN	B-NP
unit	unit	NN	I-NP
.	.	.	0
It	It	PRP	0
was	was	VBD	0
recently	recently	RB	0
reported	reported	VBN	0
by	by	IN	0
Lins	Lins	NNP	0
et	et	FW	0
al	al	FW	0
,	,	,	0
Lins	Lins	NNP	0
,	,	,	0
Roberto	Roberto	NNP	B-NP
D.	D.	NNP	I-NP
,	,	,	0
PROTEINS	PROTEINS	NNP	0
:	:	:	0
Structure	Structure	NNP	0
,	,	,	0
Function	Function	NNP	0
and	and	CC	0
bioinformatic	bioinformatic	NN	B-NP
55	55	CD	0
:	:	:	0
177-186	177-186	CD	0
(	(	-LRB-	0
2004	2004	CD	0
)	)	-RRB-	0
,	,	,	0
as	as	IN	0
a	a	DT	0
protein	protein	NN	B-NP
stabilizer	stabilizer	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
also	also	RB	0
available	available	JJ	0
from	from	IN	0
Sigma-Aldrich	Sigma-Aldrich	NNP	B-NP
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
T9531	T9531	NNP	0
(	(	-LRB-	0
dihydrate	dihydrate	JJ	B-NP
form	form	NN	I-NP
)	)	-RRB-	0
.	.	.	0
An	An	DT	0
anti-microbial	anti-microbial	JJ	B-NP
agent	agent	NN	I-NP
is	is	VBZ	0
optionally	optionally	VBN	0
included	included	VBN	0
.	.	.	0
One	One	CD	0
which	which	WDT	0
has	has	VBZ	0
been	been	VBN	0
found	found	VBN	0
to	to	TO	0
not	not	RB	0
interfere	interfere	VB	0
with	with	IN	0
ihc	ihc	NN	B-NP
requirement	requirement	NN	I-NP
is	is	VBZ	0
sodium	sodium	JJ	B-NP
azide	azide	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
available	available	JJ	0
from	from	IN	0
many	many	JJ	0
suppliers	suppliers	NNS	0
,	,	,	0
including	including	VBG	B-NP
Sigma	Sigma	NNP	I-NP
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
S-2002	S-2002	NNP	I-NP
.	.	.	0
The	The	DT	0
least	least	JJS	0
amount	amount	NN	0
appropriate	appropriate	JJ	0
to	to	TO	0
retard	retard	VB	0
microbial	microbial	JJ	B-NP
growth	growth	NN	I-NP
was	was	VBD	0
used	used	VBN	0
since	since	IN	0
it	it	PRP	0
is	is	VBZ	0
generally	generally	RB	0
toxic	toxic	JJ	B-NP
,	,	,	0
and	and	CC	0
can	can	MD	0
be	be	VB	0
explosive	explosive	JJ	B-NP
under	under	IN	0
certain	certain	JJ	0
circumstances.	circumstances.	CD	0
0.05	0.05	CD	0
wt.	wt.	CD	B-NP
/	/	CD	0
vol.	vol.	CD	B-NP
%	%	NN	0
0.1	0.1	CD	0
%	%	NN	0
is	is	VBZ	0
a	a	DT	0
generally	generally	RB	0
preferred	preferred	JJ	0
range	range	NN	0
,	,	,	0
and	and	CC	0
0.08	0.08	CD	0
%	%	NN	0
is	is	VBZ	0
a	a	DT	0
preferred	preferred	JJ	0
concentration	concentration	NN	B-NP
used	used	VBN	0
herein	herein	NN	0
.	.	.	0
A	A	DT	0
background	background	NN	0
blocking	blocking	VBG	B-NP
agent	agent	NN	I-NP
is	is	VBZ	0
generally	generally	RB	0
used	used	VBN	0
with	with	IN	0
antibody	antibody	NN	B-NP
diluents	diluents	VBZ	0
so	so	RB	0
that	that	IN	0
non-specific	non-specific	JJ	B-NP
protein-protein	protein-protein	JJ	I-NP
binding	binding	NN	I-NP
is	is	VBZ	0
minimized	minimized	VBN	0
in	in	IN	0
subsequent	subsequent	JJ	0
staining	staining	NN	0
runs	runs	VBZ	0
.	.	.	0
Non-specific	Non-specific	JJ	B-NP
protein-protein	protein-protein	JJ	I-NP
binding	binding	NN	I-NP
may	may	MD	0
occur	occur	VB	0
between	between	IN	0
the	the	DT	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
and	and	CC	0
many	many	JJ	0
other	other	JJ	0
proteins	proteins	NNS	0
in	in	IN	0
the	the	DT	0
tissue	tissue	NN	0
sample	sample	NN	0
,	,	,	0
so	so	RB	0
some	some	DT	0
method	method	NN	0
of	of	IN	0
quenching	quenching	VBG	0
this	this	DT	0
stickiness	stickiness	NN	0
should	should	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
background	background	NN	B-NP
signal	signal	NN	I-NP
.	.	.	0
Many	Many	JJ	0
proteins	proteins	NNS	0
can	can	MD	0
be	be	VB	0
used	used	VBN	0
for	for	IN	0
this	this	DT	0
,	,	,	0
including	including	VBG	0
Bovine	Bovine	NNP	B-NP
Serum	Serum	NNP	I-NP
Albumin	Albumin	NNP	I-NP
(	(	-LRB-	0
BSA	BSA	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
Bovine	Bovine	NNP	B-NP
Gamma	Gamma	NNP	I-NP
Globulin	Globulin	NNP	I-NP
(	(	-LRB-	0
BGG	BGG	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
hydrolyzed	hydrolyzed	JJ	B-NP
casein	casein	NN	I-NP
.	.	.	0
Particularly	Particularly	RB	0
preferred	preferred	VBN	0
is	is	VBZ	0
hydrolyzed	hydrolyzed	JJ	B-NP
casein	casein	NN	I-NP
from	from	IN	0
American	American	NNP	0
Casein	Casein	NNP	B-NP
Co	Co	NNP	0
.	.	.	0
(	(	-LRB-	0
Burlington	Burlington	NNP	0
,	,	,	0
N.J.	N.J.	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
HCA-411	HCA-411	NNP	I-NP
.	.	.	0
concentration	concentration	NN	B-NP
of	of	IN	0
from	from	IN	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
to	to	TO	0
15	15	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
are	are	VBP	0
useful	useful	JJ	0
,	,	,	0
although	although	IN	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
is	is	VBZ	0
preferred	preferred	VBN	0
.	.	.	0
One	One	CD	0
of	of	IN	0
ordinary	ordinary	JJ	B-NP
skill	skill	NN	I-NP
in	in	IN	0
the	the	DT	0
histology	histology	JJ	B-NP
art	art	NN	I-NP
will	will	MD	0
know	know	VB	0
of	of	IN	0
many	many	JJ	0
interchangeable	interchangeable	NNS	0
blocking	blocking	VBG	B-NP
protein	protein	NN	I-NP
that	that	WDT	0
can	can	MD	0
be	be	VB	0
utilized	utilized	NNS	0
.	.	.	0
Individual	Individual	JJ	0
blocking	blocking	VBG	B-NP
buffer	buffer	NN	I-NP
are	are	VBP	0
not	not	RB	0
compatible	compatible	JJ	0
with	with	IN	0
every	every	DT	0
system	system	NN	0
.	.	.	0
For	For	IN	0
this	this	DT	0
reason	reason	NN	0
,	,	,	0
a	a	DT	0
variety	variety	NN	0
of	of	IN	0
blocker	blocker	NNP	B-NP
in	in	IN	0
both	both	DT	0
tri	tri	NNP	B-NP
buffered	buffered	FW	0
saline	saline	FW	0
(	(	-LRB-	0
TBS	TBS	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
phosphate	phosphate	NN	B-NP
buffered	buffered	FW	0
saline	saline	FW	0
(	(	-LRB-	0
PBS	PBS	NNP	B-NP
)	)	-RRB-	0
are	are	VBP	0
available	available	JJ	0
.	.	.	0
The	The	DT	0
proper	proper	JJ	0
choice	choice	NN	0
of	of	IN	0
blocker	blocker	NN	B-NP
for	for	IN	0
a	a	DT	0
given	given	VBN	0
tissue	tissue	NN	0
depends	depends	VBZ	0
on	on	IN	0
the	the	DT	0
antigen	antigen	NN	B-NP
itself	itself	PRP	0
and	and	CC	0
on	on	IN	0
the	the	DT	0
type	type	NN	0
of	of	IN	0
enzyme	enzyme	JJ	B-NP
conjugate	conjugate	NN	0
to	to	TO	0
be	be	VB	0
used	used	VBN	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
with	with	IN	0
application	application	NN	B-NP
using	using	VBG	0
an	an	DT	0
alkaline	alkaline	JJ	B-NP
phosphatase	phosphatase	JJ	I-NP
conjugate	conjugate	NN	0
,	,	,	0
a	a	DT	0
blocking	blocking	JJ	0
buffer	buffer	NN	B-NP
in	in	IN	0
tri	tri	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
should	should	MD	0
be	be	VB	0
selected	selected	VBN	0
,	,	,	0
because	because	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
interferes	interferes	VBZ	0
with	with	IN	0
alkaline	alkaline	JJ	B-NP
phosphatase	phosphatase	NN	I-NP
.	.	.	0
The	The	DT	0
ideal	ideal	NN	0
blocking	blocking	VBG	B-NP
buffer	buffer	NN	I-NP
will	will	MD	0
bind	bind	VB	0
to	to	TO	0
all	all	DT	0
nonspecific	nonspecific	JJ	B-NP
interaction	interaction	NN	I-NP
potential	potential	JJ	I-NP
site	site	NN	I-NP
,	,	,	0
eliminating	eliminating	VBG	B-NP
background	background	NN	I-NP
altogether	altogether	RB	0
without	without	IN	0
altering	altering	VBG	0
or	or	CC	0
obscuring	obscuring	VBG	0
the	the	DT	0
epitope	epitope	NN	B-NP
for	for	IN	0
antibody	antibody	NN	0
binding	binding	NN	0
.	.	.	0
For	For	IN	0
true	true	JJ	0
optimization	optimization	NN	B-NP
of	of	IN	0
the	the	DT	0
blocking	blocking	JJ	0
step	step	NN	0
for	for	IN	0
a	a	DT	0
particular	particular	JJ	0
immunohistochemical	immunohistochemical	JJ	B-NP
assay	assay	NN	I-NP
,	,	,	0
empirical	empirical	JJ	B-NP
testing	testing	NN	I-NP
is	is	VBZ	0
essential	essential	JJ	0
.	.	.	0
Many	Many	JJ	0
factors	factors	NNS	0
,	,	,	0
including	including	VBG	0
various	various	JJ	0
protein	protein	NN	B-NP
:	:	:	0
protein	protein	NN	B-NP
interaction	interaction	NN	I-NP
unique	unique	JJ	0
to	to	TO	0
a	a	DT	0
given	given	VBN	0
set	set	VBN	0
of	of	IN	0
immunoassay	immunoassay	JJ	B-NP
reagent	reagent	NN	I-NP
,	,	,	0
can	can	MD	0
influence	influence	VB	0
nonspecific	nonspecific	JJ	B-NP
binding	binding	NN	I-NP
.	.	.	0
The	The	DT	0
most	most	RBS	0
important	important	JJ	0
parameter	parameter	NN	0
when	when	WRB	0
selecting	selecting	VBG	0
a	a	DT	0
blocker	blocker	NN	B-NP
is	is	VBZ	0
the	the	DT	0
signal	signal	NN	0
:	:	:	0
noise	noise	NN	B-NP
ratio	ratio	NN	I-NP
,	,	,	0
measured	measured	VBN	0
as	as	IN	0
the	the	DT	0
signal	signal	NN	0
obtained	obtained	VBN	0
with	with	IN	0
a	a	DT	0
tissue	tissue	NN	0
sample	sample	NN	0
containing	containing	VBG	0
the	the	DT	0
target	target	NN	B-NP
analyte	analyte	NN	I-NP
,	,	,	0
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
that	that	DT	0
obtained	obtained	VBN	0
with	with	IN	0
a	a	DT	0
sample	sample	NN	0
without	without	IN	0
the	the	DT	0
target	target	NN	B-NP
analyte	analyte	NN	I-NP
.	.	.	0
Using	Using	VBG	0
inadequate	inadequate	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
blocker	blocker	NN	B-NP
will	will	MD	0
result	result	VB	0
in	in	IN	0
excessive	excessive	JJ	B-NP
background	background	NN	I-NP
staining	staining	NNS	0
and	and	CC	0
a	a	DT	0
reduced	reduced	JJ	0
signal	signal	NN	0
:	:	:	0
noise	noise	NN	B-NP
ratio	ratio	NN	I-NP
.	.	.	0
Using	Using	VBG	0
blocker	blocker	NN	B-NP
excessive	excessive	JJ	I-NP
concentration	concentration	NN	I-NP
may	may	MD	0
mask	mask	VB	0
antibody	antibody	NN	B-NP
:	:	:	0
antigen	antigen	JJ	B-NP
interaction	interaction	NN	I-NP
or	or	CC	0
inhibit	inhibit	VB	0
the	the	DT	0
marker	marker	JJ	B-NP
enzyme	enzyme	NN	I-NP
,	,	,	0
again	again	RB	0
causing	causing	VBG	0
a	a	DT	0
reduction	reduction	NN	0
of	of	IN	0
the	the	DT	0
signal	signal	NN	0
:	:	:	0
noise	noise	NN	B-NP
ratio	ratio	NN	I-NP
.	.	.	0
When	When	WRB	0
developing	developing	VBG	0
any	any	DT	0
new	new	JJ	0
immunoassay	immunoassay	NN	B-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
important	important	JJ	0
to	to	TO	0
test	test	VB	0
several	several	JJ	0
different	different	JJ	0
blocker	blocker	NNP	B-NP
for	for	IN	0
the	the	DT	0
highest	highest	JJS	0
signal	signal	NN	0
:	:	:	0
noise	noise	NN	B-NP
ratio	ratio	NN	I-NP
in	in	IN	0
the	the	DT	0
assay	assay	NN	B-NP
.	.	.	0
No	No	DT	0
single	single	JJ	0
blocking	blocking	VBG	B-NP
agent	agent	NN	I-NP
is	is	VBZ	0
ideal	ideal	VBN	0
for	for	IN	0
every	every	DT	0
occasion	occasion	NN	0
since	since	IN	0
each	each	DT	0
antibody-antigen	antibody-antigen	JJ	B-NP
pair	pair	NN	I-NP
has	has	VBZ	0
unique	unique	JJ	0
characteristics	characteristics	NNS	0
.	.	.	0
Agents	Agents	NNS	0
such	such	JJ	0
as	as	IN	0
nonfat	nonfat	JJ	B-NP
dry	dry	JJ	I-NP
milk	milk	NN	I-NP
and	and	CC	0
salmon	salmon	JJ	B-NP
serum	serum	NN	I-NP
,	,	,	0
in	in	IN	0
addition	addition	NN	0
to	to	TO	0
those	those	DT	0
mentioned	mentioned	VBN	0
above	above	IN	0
,	,	,	0
may	may	MD	0
be	be	VB	0
used	used	VBN	0
.	.	.	0
Formulation	Formulation	NNP	B-NP
1	1	CD	0
is	is	VBZ	0
50	50	CD	0
mmol	mmol	JJ	B-NP
Trizmag	Trizmag	NNP	I-NP
HCl	HCl	NNP	I-NP
,	,	,	0
100	100	CD	0
mmol	mmol	JJ	B-NP
mannitol	mannitol	NN	I-NP
,	,	,	0
2	2	CD	0
mg	mg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
hydrolyzed	hydrolyzed	NN	I-NP
casein	casein	NN	I-NP
and	and	CC	0
sodium	sodium	CD	B-NP
azide	azide	CD	I-NP
0.08	0.08	CD	0
%	%	NN	0
.	.	.	0
This	This	DT	0
formulation	formulation	NN	B-NP
was	was	VBD	0
used	used	VBN	0
in	in	IN	0
the	the	DT	0
examples	examples	NNS	0
below	below	IN	0
to	to	TO	0
dilute	dilute	VB	0
the	the	DT	0
antibody	antibody	NN	B-NP
mentioned	mentioned	VBN	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
referred	referred	VBN	0
to	to	TO	0
as	as	IN	0
the	the	DT	0
TBMC	TBMC	NNP	B-NP
diluent	diluent	NN	I-NP
.	.	.	0
Prior	Prior	JJ	0
art	art	NN	0
diluent	diluent	VBD	0
md	md	NN	B-NP
is	is	VBZ	0
77	77	CD	0
mM	mM	JJ	B-NP
Sodium	Sodium	NNP	I-NP
Phosphate	Phosphate	NNP	I-NP
,	,	,	0
dibasic	dibasic	NN	B-NP
;	;	:	0
23	23	CD	0
mM	mM	JJ	B-NP
Sodium	Sodium	NNP	I-NP
Phosphate	Phosphate	NNP	I-NP
,	,	,	0
monobasic	monobasic	NN	B-NP
;	;	:	0
54.75	54.75	CD	0
mM	mM	JJ	B-NP
Sodium	Sodium	NNP	I-NP
Chloride	Chloride	NNP	I-NP
;	;	:	0
0.05	0.05	CD	0
%	%	NN	0
Brij	Brij	NNP	B-NP
35	35	CD	0
;	;	:	0
15.0	15.0	FW	0
mg	mg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
Hydrolyzed	Hydrolyzed	NNP	I-NP
Casein	Casein	NNP	I-NP
Protein	Protein	NNP	I-NP
;	;	:	0
0.05	0.05	CD	0
%	%	NN	0
ProClin	ProClin	JJ	0
300	300	CD	0
.	.	.	0
TBST	TBST	NNP	B-NP
diluent	diluent	NN	I-NP
is	is	VBZ	0
19.98	19.98	NNP	0
mM	mM	NNP	B-NP
Trizma	Trizma	NNP	I-NP
Base	Base	NNP	I-NP
;	;	:	0
136.89	136.89	NNP	0
mM	mM	NNP	B-NP
Sodium	Sodium	NNP	I-NP
Chloride	Chloride	NNP	I-NP
;	;	:	0
0.1	0.1	CD	0
%	%	NN	0
Tween	Tween	NNP	B-NP
20	20	CD	0
;	;	:	0
5	5	CD	0
%	%	NN	0
Normal	Normal	NNP	B-NP
Goat	Goat	NNP	I-NP
Serum	Serum	NNP	I-NP
(	(	-LRB-	0
Chemicon	Chemicon	NNP	B-NP
International	International	NNP	0
,	,	,	0
Temecula	Temecula	NNP	B-NP
,	,	,	0
Calif.	Calif.	NNP	0
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
S26	S26	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
stabilities	stabilities	NN	0
of	of	IN	0
two	two	CD	0
antibody	antibody	NN	B-NP
,	,	,	0
anti-pERK	anti-pERK	JJ	B-NP
and	and	CC	0
leucocyte	leucocyte	NN	B-NP
common	common	JJ	I-NP
antigen	antigen	NN	I-NP
,	,	,	0
were	were	VBD	0
compared	compared	VBN	0
to	to	TO	0
their	their	PRP$	0
stability	stability	NN	0
in	in	IN	0
the	the	DT	0
novel	novel	NN	B-NP
TBMC	TBMC	NNP	I-NP
diluent	diluent	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
prior	prior	JJ	0
art	art	NN	B-NP
md	md	NN	I-NP
and	and	CC	0
tbst	tbst	NN	B-NP
diluent	diluent	NN	I-NP
,	,	,	0
at	at	IN	0
the	the	DT	0
elevated	elevated	JJ	0
temperature	temperature	NN	0
of	of	IN	0
45	45	CD	0
C.	C.	NNP	0
,	,	,	0
a	a	DT	0
standard	standard	JJ	0
ship-stress	ship-stress	JJ	B-NP
test	test	NN	I-NP
temperature	temperature	NN	I-NP
.	.	.	0
Anti-CD45	Anti-CD45	NNP	B-NP
Leucocyte	Leucocyte	NNP	I-NP
Common	Common	NNP	I-NP
Antigen	Antigen	NNP	I-NP
(	(	-LRB-	0
LCA	LCA	NNP	B-NP
)	)	-RRB-	0
clone	clone	JJ	B-NP
2B11	2B11	NN	I-NP
from	from	IN	0
neomarker	neomarker	NN	B-NP
,	,	,	0
Inc.	Inc.	NNP	0
,	,	,	0
Fremont	Fremont	NNP	0
,	,	,	0
Calif.	Calif.	NNP	0
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
MS-1884-P0	MS-1884-P0	NNP	I-NP
was	was	VBD	0
used.	used.	CD	0
4	4	CD	0
m	m	CD	0
tonsil	tonsil	CD	0
sections	sections	NNS	0
were	were	VBD	0
prepared	prepared	VBN	0
for	for	IN	0
staining	staining	NN	0
on	on	IN	0
a	a	DT	0
DISCOVERY	DISCOVERY	FW	0
automated	automated	VBN	B-NP
tissue	tissue	NN	I-NP
stainer	stainer	NN	I-NP
(	(	-LRB-	0
Ventana	Ventana	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
present	present	JJ	0
diluent	diluent	NN	B-NP
md	md	NN	I-NP
is	is	VBZ	0
hostile	hostile	JJ	0
to	to	TO	0
the	the	DT	0
stability	stability	NN	0
of	of	IN	0
phosphorylated	phosphorylated	JJ	B-NP
antibody	antibody	NN	I-NP
,	,	,	0
as	as	RB	0
seen	seen	VBN	0
in	in	IN	0
FIG.	FIG.	CD	0
4	4	CD	0
in	in	IN	0
the	the	DT	0
top	top	JJ	0
three	three	CD	0
frames	frames	NNS	0
diluent	diluent	NN	B-NP
day	day	NN	I-NP
x	x	NN	I-NP
labeled	labeled	VBD	I-NP
md	md	NN	I-NP
,	,	,	0
where	where	WRB	0
X	X	NNP	0
is	is	VBZ	0
0	0	CD	0
in	in	IN	0
the	the	DT	0
first	first	JJ	0
frame	frame	NN	0
,	,	,	0
and	and	CC	0
increases	increases	NNS	0
with	with	IN	0
increasing	increasing	VBG	B-NP
time	time	NN	I-NP
in	in	IN	0
the	the	DT	0
diluent	diluent	NN	B-NP
to	to	TO	0
14	14	CD	0
days	days	NNS	0
in	in	IN	0
the	the	DT	0
last	last	JJ	0
frame	frame	NN	0
.	.	.	0
By	By	IN	0
the	the	DT	0
last	last	JJ	0
frame	frame	NN	0
(	(	-LRB-	0
Day	Day	NNP	0
14	14	CD	0
)	)	-RRB-	0
all	all	DT	0
antibody	antibody	NN	0
activity	activity	NN	0
is	is	VBZ	0
gone	gone	VBN	0
in	in	IN	0
the	the	DT	0
diluent	diluent	NN	B-NP
md	md	NN	I-NP
,	,	,	0
whereas	whereas	VBG	0
in	in	IN	0
the	the	DT	0
TBMC	TBMC	NNP	B-NP
diluent	diluent	VBD	0
the	the	DT	0
LCA	LCA	NNP	B-NP
antibody	antibody	NN	I-NP
is	is	VBZ	0
still	still	RB	0
staining	staining	VB	0
the	the	DT	0
tonsil	tonsil	JJ	0
sections	sections	NNS	0
well	well	RB	0
.	.	.	0
We	We	PRP	0
then	then	RB	0
looked	looked	VBN	0
at	at	IN	0
the	the	DT	0
stability	stability	NN	0
of	of	IN	0
phospho-ERK	phospho-ERK	NNP	B-NP
(	(	-LRB-	0
pERK	pERK	NNP	0
)	)	-RRB-	0
from	from	IN	0
Biosource	Biosource	NNP	B-NP
International	International	NNP	0
,	,	,	0
Camarillo	Camarillo	NNP	0
,	,	,	0
Calif.	Calif.	NNP	0
,	,	,	0
P	P	NNP	0
/	/	NNP	0
N	N	NNP	0
44-680G	44-680G	NNP	0
in	in	IN	0
the	the	DT	0
TBMC	TBMC	NNP	B-NP
diluent	diluent	NN	I-NP
and	and	CC	0
in	in	IN	0
TBST	TBST	NNP	B-NP
diluent	diluent	NN	I-NP
.	.	.	0
In	In	IN	0
FIG.	FIG.	CD	0
5	5	CD	0
,	,	,	0
the	the	DT	0
top	top	JJ	0
three	three	CD	0
frames	frames	NNS	0
show	show	VBP	0
the	the	DT	0
pERK	pERK	JJ	B-NP
antibody	antibody	NN	I-NP
diluted	diluted	VBN	0
in	in	IN	0
TBMC	TBMC	NNP	B-NP
diluent	diluent	NN	I-NP
,	,	,	0
and	and	CC	0
in	in	IN	0
TBST	TBST	NNP	B-NP
diluent	diluent	NN	I-NP
(	(	-LRB-	0
bottom	bottom	JJ	0
three	three	CD	0
frames	frames	NNS	0
)	)	-RRB-	0
at	at	IN	0
time=0	time=0	NNP	0
,	,	,	0
7	7	CD	0
days	days	NNS	0
,	,	,	0
and	and	CC	0
14	14	CD	0
days	days	NNS	0
.	.	.	0
Stability	Stability	NN	0
in	in	IN	0
both	both	DT	0
diluent	diluent	NN	B-NP
is	is	VBZ	0
apparent	apparent	JJ	0
.	.	.	0
The	The	DT	0
sections	sections	JJ	0
stained	stained	NN	0
were	were	VBD	0
4	4	CD	0
um	um	JJ	B-NP
breast	breast	NN	I-NP
carcinoma	carcinoma	NN	I-NP
section	section	NN	I-NP
sourced	sourced	VBN	0
from	from	IN	0
the	the	DT	0
ventana	ventana	NN	B-NP
tissue	tissue	NN	I-NP
bank	bank	NN	I-NP
in-house	in-house	JJ	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
those	those	DT	0
of	of	IN	0
ordinary	ordinary	JJ	B-NP
skill	skill	NN	I-NP
will	will	MD	0
appreciate	appreciate	VB	0
that	that	IN	0
any	any	DT	0
breast	breast	NN	B-NP
carcinoma	carcinoma	NN	I-NP
tissue	tissue	NN	I-NP
expresses	expresses	VBZ	0
pERK	pERK	JJ	0
,	,	,	0
and	and	CC	0
so	so	RB	0
any	any	DT	0
breast	breast	NN	0
tumor	tumor	NN	0
tissue	tissue	NN	0
may	may	MD	0
be	be	VB	0
used	used	VBN	0
.	.	.	0
Quantum	Quantum	NNP	0
Dots	Dots	NNPS	0
are	are	VBP	0
semiconductor	semiconductor	JJ	B-NP
nanocrystal-based	nanocrystal-based	JJ	I-NP
fluorescent	fluorescent	JJ	0
tags	tags	NNS	0
that	that	WDT	0
are	are	VBP	0
being	being	VBG	0
used	used	VBN	0
in	in	IN	0
life	life	NN	B-NP
sciences	sciences	NN	I-NP
research	research	NN	I-NP
due	due	JJ	0
to	to	TO	0
their	their	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
emit	emit	VB	0
narrow	narrow	JJ	0
frequencies	frequencies	NN	0
of	of	IN	0
light	light	NN	0
when	when	WRB	0
appropriately	appropriately	RB	0
excited	excited	VBN	0
.	.	.	0
They	They	PRP	0
can	can	MD	0
be	be	VB	0
conjugated	conjugated	VBN	0
to	to	TO	0
biomolecules	biomolecules	VB	0
such	such	JJ	0
as	as	IN	0
hapten	hapten	NN	B-NP
,	,	,	0
antibody	antibody	NN	B-NP
or	or	CC	0
dna	dna	NN	B-NP
probe	probe	NN	I-NP
,	,	,	0
and	and	CC	0
then	then	RB	0
bound	bound	VBN	0
or	or	CC	0
hybridized	hybridized	JJ	0
to	to	TO	0
their	their	PRP$	0
respective	respective	JJ	0
biological	biological	JJ	B-NP
target	target	NN	I-NP
.	.	.	0
FIG.	FIG.	CD	0
1	1	CD	0
shows	shows	NNS	0
the	the	DT	0
problems	problems	NNS	0
encountered	encountered	VBD	0
with	with	IN	0
the	the	DT	0
prior	prior	JJ	0
diluent	diluent	NN	B-NP
art	art	NN	I-NP
md	md	NN	I-NP
with	with	IN	0
the	the	DT	0
QDot	QDot	JJ	0
-Streptavidin	-Streptavidin	JJ	0
conjugate	conjugate	NN	0
when	when	WRB	0
used	used	VBN	0
to	to	TO	0
detect	detect	VB	0
the	the	DT	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
anti-Ki-67	anti-Ki-67	NN	I-NP
,	,	,	0
clone	clone	NN	B-NP
K-2	K-2	NN	I-NP
(	(	-LRB-	0
Ventana	Ventana	NNP	B-NP
P	P	NNP	I-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
790-2910	790-2910	NNP	0
)	)	-RRB-	0
.	.	.	0
4	4	LS	0
um	um	JJ	B-NP
tonsil	tonsil	JJ	I-NP
section	section	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
for	for	IN	0
staining	staining	NN	0
on	on	IN	0
a	a	DT	0
DISCOVERY	DISCOVERY	NNP	B-NP
system	system	NN	I-NP
,	,	,	0
as	as	RB	0
before	before	RB	0
.	.	.	0
QDot	QDot	JJ	0
605	605	CD	0
conjugated	conjugated	NN	0
to	to	TO	0
Streptavidin	Streptavidin	NNP	B-NP
(	(	-LRB-	0
Invitrogen	Invitrogen	NNP	B-NP
Corp.	Corp.	NNP	0
,	,	,	0
Carlsbad	Carlsbad	NNP	B-NP
,	,	,	0
Calif.	Calif.	NNP	0
,	,	,	0
P	P	NNP	B-NP
/	/	NNP	I-NP
N	N	NNP	I-NP
Q21301MP	Q21301MP	NNP	0
)	)	-RRB-	0
was	was	VBD	0
diluted	diluted	VBN	0
into	into	IN	0
both	both	PDT	0
the	the	DT	0
prior	prior	JJ	0
diluent	diluent	NN	B-NP
art	art	NN	I-NP
md	md	NN	I-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
casein	casein	NN	B-NP
/	/	NN	I-NP
Sodium	Sodium	NN	I-NP
azide	azide	NN	I-NP
diluent	diluent	NN	I-NP
(	(	-LRB-	0
2	2	LS	0
ug	ug	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
hydrolyzed	hydrolyzed	NN	I-NP
casein	casein	NN	I-NP
;	;	:	0
0.08	0.08	CD	0
%	%	NN	0
NaN3	NaN3	CD	B-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
two	two	CD	0
left	left	JJ	0
frames	frames	NNS	0
show	show	VBP	0
tonsil	tonsil	JJ	0
sections	sections	NNS	0
stained	stained	VBN	0
with	with	IN	0
the	the	DT	0
Ki67	Ki67	NNP	B-NP
/	/	NNP	0
QDot	QDot	NNP	B-NP
605	605	CD	0
combination	combination	NN	0
diluted	diluted	VBN	0
into	into	IN	0
the	the	DT	0
diluent	diluent	NN	B-NP
md	md	NN	I-NP
on	on	IN	0
Day	Day	NNP	0
0.	0.	NNP	0
(	(	-LRB-	0
top-left	top-left	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
Day	Day	NNP	0
1	1	CD	0
(	(	-LRB-	0
bottom	bottom	NN	0
left	left	VBN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
signal	signal	NN	0
clearly	clearly	RB	0
declines	declines	VBZ	0
rapidly	rapidly	RB	0
to	to	TO	0
being	being	VBG	B-NP
non-existent	non-existent	JJ	I-NP
on	on	IN	0
Day	Day	NNP	0
1	1	CD	0
.	.	.	0
By	By	IN	0
contrast	contrast	NN	0
,	,	,	0
switching	switching	VBG	0
to	to	TO	0
a	a	DT	0
casein-only	casein-only	JJ	0
diluent	diluent	NN	B-NP
reduces	reduces	VBZ	0
the	the	DT	0
fading	fading	NN	0
of	of	IN	0
the	the	DT	0
QDot	QDot	JJ	0
605	605	CD	0
signal	signal	NN	0
greatly	greatly	RB	0
so	so	RB	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
apparent	apparent	JJ	0
fading	fading	NN	0
between	between	IN	0
Day	Day	NNP	0
0	0	CD	0
and	and	CC	0
Day	Day	NNP	0
1	1	CD	0
.	.	.	0
Clearly	Clearly	RB	0
,	,	,	0
the	the	DT	0
diluent	diluent	NN	B-NP
md	md	NN	I-NP
is	is	VBZ	0
not	not	RB	0
friendly	friendly	JJ	0
to	to	TO	0
QDot	QDot	JJ	0
conjugate	conjugate	JJ	0
stability	stability	NN	0
at	at	IN	0
37	37	CD	0
C	C	NNP	0
.	.	.	0
FIG.	FIG.	CD	0
2	2	CD	0
shows	shows	NNS	0
the	the	DT	0
effect	effect	NN	B-NP
casein	casein	NN	I-NP
seems	seems	VBZ	0
to	to	TO	0
have	have	VB	0
in	in	IN	0
the	the	DT	0
TBMC	TBMC	NNP	B-NP
diluent	diluent	NN	I-NP
.	.	.	0
The	The	DT	0
figure	figure	NN	0
shows	shows	VBZ	0
a	a	DT	0
different	different	JJ	0
being	being	VBG	B-NP
stained	stained	NN	I-NP
antibody	antibody	NN	I-NP
anti-cd45	anti-cd45	NN	I-NP
antibody	antibody	NN	I-NP
lca	lca	NN	I-NP
on	on	IN	0
tonsil	tonsil	JJ	0
sections	sections	NNS	0
,	,	,	0
and	and	CC	0
then	then	RB	0
being	being	VBG	0
detected	detected	VBN	0
using	using	VBG	0
the	the	DT	0
same	same	JJ	0
QDot-Streptavidin	QDot-Streptavidin	JJ	B-NP
605	605	CD	0
conjugate	conjugate	NNS	0
.	.	.	0
This	This	DT	0
figure	figure	NN	B-NP
show	show	NN	I-NP
that	that	IN	0
the	the	DT	0
blocking	blocking	VBG	B-NP
protein	protein	NN	I-NP
behave	behave	VBP	0
surprisingly	surprisingly	RB	0
differently	differently	RB	0
diluent	diluent	NN	B-NP
regarding	regarding	VBG	I-NP
stability	stability	NN	I-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
the	the	DT	0
signals	signals	NNS	0
degrade	degrade	VBP	0
most	most	RBS	0
rapidly	rapidly	RB	0
in	in	IN	0
bovine	bovine	JJ	B-NP
gamma	gamma	NN	I-NP
globulin	globulin	NN	I-NP
(	(	-LRB-	0
bovine	bovine	JJ	B-NP
gamma	gamma	NN	I-NP
globulin	globulin	NN	I-NP
,	,	,	0
bottom	bottom	JJ	0
right	right	NN	0
)	)	-RRB-	0
,	,	,	0
then	then	RB	0
degrade	degrade	VBN	0
significantly	significantly	RB	0
in	in	IN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
albumin	albumin	NN	I-NP
(	(	-LRB-	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
albumin	albumin	NN	I-NP
,	,	,	0
top	top	JJ	0
right	right	NN	0
)	)	-RRB-	0
then	then	RB	0
not	not	RB	0
at	at	IN	0
all	all	DT	0
in	in	IN	0
casein	casein	NN	B-NP
(	(	-LRB-	0
top	top	JJ	0
left	left	NN	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
were	were	VBD	0
generated	generated	VBN	0
at	at	IN	0
45	45	CD	0
C	C	NNP	0
.	.	.	0
FIG.	FIG.	CD	0
3	3	CD	0
is	is	VBZ	0
a	a	DT	0
longer	longer	JJR	0
term	term	NN	0
(	(	-LRB-	0
5	5	CD	0
days	days	NNS	0
versus	versus	IN	0
two	two	CD	0
)	)	-RRB-	0
and	and	CC	0
higher	higher	JJR	0
temperature	temperature	NN	0
(	(	-LRB-	0
45	45	CD	0
v.	v.	CC	0
37	37	CD	0
)	)	-RRB-	0
test	test	NN	0
of	of	IN	0
the	the	DT	0
TBMC	TBMC	NNP	B-NP
diluent	diluent	VBD	0
discussed	discussed	VBN	0
in	in	IN	0
FIG.	FIG.	CD	0
2	2	CD	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
are	are	VBP	0
similar	similar	JJ	0
,	,	,	0
with	with	IN	0
increased	increased	JJ	0
degradation	degradation	NN	0
of	of	IN	0
signal	signal	NN	0
over	over	IN	0
the	the	DT	0
extra	extra	JJ	0
time	time	NN	0
and	and	CC	0
higher	higher	JJR	0
temperatures	temperatures	NNS	0
in	in	IN	0
all	all	DT	0
diluent	diluent	NN	B-NP
.	.	.	0
While	While	IN	0
the	the	DT	0
invention	invention	NN	0
has	has	VBZ	0
been	been	VBN	0
described	described	VBN	0
with	with	IN	0
reference	reference	NN	0
to	to	TO	0
an	an	DT	0
illustrative	illustrative	JJ	0
embodiment	embodiment	NN	0
,	,	,	0
it	it	PRP	0
will	will	MD	0
be	be	VB	0
understood	understood	VBN	0
by	by	IN	0
those	those	DT	0
skilled	skilled	JJ	0
in	in	IN	0
the	the	DT	0
art	art	NN	0
that	that	IN	0
various	various	JJ	0
changes	changes	NNS	0
,	,	,	0
omissions	omissions	NNS	0
and	and	CC	0
/	/	NNP	0
or	or	CC	0
additions	additions	NNS	0
may	may	MD	0
be	be	VB	0
made	made	VBN	0
and	and	CC	0
equivalents	equivalents	NNS	0
may	may	MD	0
be	be	VB	0
substituted	substituted	VBN	0
for	for	IN	0
elements	elements	NNS	0
thereof	thereof	RB	0
without	without	IN	0
departing	departing	VBG	0
from	from	IN	0
the	the	DT	0
spirit	spirit	NN	0
and	and	CC	0
scope	scope	NN	0
of	of	IN	0
the	the	DT	0
invention	invention	NN	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
many	many	JJ	0
modification	modification	NN	B-NP
may	may	MD	0
be	be	VB	0
made	made	VBN	0
to	to	TO	0
adapt	adapt	VB	0
a	a	DT	0
particular	particular	JJ	0
situation	situation	NN	0
or	or	CC	0
material	material	NN	0
to	to	TO	0
the	the	DT	0
teachings	teachings	NN	0
of	of	IN	0
the	the	DT	0
invention	invention	NN	0
without	without	IN	0
departing	departing	VBG	0
from	from	IN	0
the	the	DT	0
scope	scope	NN	0
thereof	thereof	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
intended	intended	VBN	0
that	that	IN	0
the	the	DT	0
invention	invention	NN	0
not	not	RB	0
be	be	VB	0
limited	limited	VBN	0
to	to	TO	0
the	the	DT	0
particular	particular	JJ	0
embodiments	embodiments	NNS	0
disclosed	disclosed	VBN	0
as	as	IN	0
the	the	DT	0
best	best	JJS	0
mode	mode	NN	0
contemplated	contemplated	VBN	0
for	for	IN	0
carrying	carrying	VBG	0
out	out	RP	0
this	this	DT	0
invention	invention	NN	0
,	,	,	0
but	but	CC	0
that	that	IN	0
the	the	DT	0
invention	invention	NN	0
will	will	MD	0
include	include	VB	0
all	all	DT	0
embodiments	embodiments	NN	0
falling	falling	VBG	0
within	within	IN	0
the	the	DT	0
scope	scope	NN	0
of	of	IN	0
the	the	DT	0
appended	appended	JJ	0
claims	claims	NNS	0
.	.	.	0
We	We	PRP	0
claim	claim	VBP	0
:	:	:	0
1	1	LS	0
.	.	.	0
A	A	DT	0
stabilizing	stabilizing	VBG	B-NP
biomolecule	biomolecule	NN	I-NP
diluent	diluent	NN	I-NP
,	,	,	0
comprising	comprising	VBG	B-NP
tri	tri	NNP	I-NP
and	and	CC	0
a	a	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	NN	I-NP
selected	selected	VBN	0
from	from	IN	0
the	the	DT	0
group	group	NN	0
consisting	consisting	VBG	0
of	of	IN	0
mannitol	mannitol	NN	B-NP
and	and	CC	0
trehalose.	trehalose.	CD	B-NP
2	2	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
wherein	wherein	JJ	0
casein	casein	NN	B-NP
is	is	VBZ	0
optionally	optionally	VBN	0
added	added	VBN	0
as	as	IN	0
a	a	DT	0
background	background	NN	0
blocking	blocking	VBG	B-NP
protein.	protein.	CD	I-NP
3	3	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
wherein	wherein	CD	0
the	the	DT	0
Tris	Tris	JJ	B-NP
concentration	concentration	NN	I-NP
is	is	VBZ	0
effective	effective	JJ	0
to	to	TO	0
buffer	buffer	VB	B-NP
the	the	DT	0
pH	pH	JJ	0
to	to	TO	0
between	between	IN	0
about	about	IN	0
6.8	6.8	CD	0
and	and	CC	0
about	about	IN	0
7.8.	7.8.	CD	0
4	4	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
wherein	wherein	CD	0
the	the	DT	0
polyhydroxy	polyhydroxy	JJ	B-NP
carbohydrate	carbohydrate	JJ	I-NP
range	range	NN	I-NP
concentration	concentration	NN	I-NP
from	from	IN	0
about	about	IN	0
100	100	CD	0
to	to	TO	0
about	about	RB	0
400	400	CD	0
mmol.	mmol.	CD	B-NP
5	5	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
2	2	CD	0
wherein	wherein	CD	0
the	the	DT	0
casein	casein	JJ	B-NP
range	range	NN	I-NP
concentration	concentration	NN	I-NP
from	from	IN	0
about	about	IN	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
to	to	TO	0
about	about	RB	0
15	15	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml.	ml.	CD	I-NP
6	6	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
wherein	wherein	JJ	0
optionally	optionally	NN	0
is	is	VBZ	0
included	included	VBN	B-NP
sodium	sodium	JJ	I-NP
azide	azide	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
azide	azide	JJ	B-NP
range	range	NN	I-NP
sodium	sodium	JJ	I-NP
concentration	concentration	NN	I-NP
from	from	IN	0
about	about	IN	0
0.05	0.05	CD	0
to	to	TO	0
about	about	RB	0
0.10	0.10	CD	0
%	%	NN	0
,	,	,	0
wt.	wt.	CD	B-NP
/	/	CD	0
vol.	vol.	CD	B-NP
7	7	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
wherein	wherein	CD	0
the	the	DT	0
Tris	Tris	JJ	B-NP
concentration	concentration	NN	I-NP
is	is	VBZ	0
about	about	RB	0
50	50	CD	0
mM.	mM.	CD	0
8	8	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
wherein	wherein	CD	0
the	the	DT	0
mannitol	mannitol	JJ	B-NP
concentration	concentration	NN	I-NP
is	is	VBZ	0
about	about	RB	0
100	100	CD	0
mM.	mM.	CD	0
9	9	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
2	2	CD	0
wherein	wherein	CD	0
the	the	DT	0
casein	casein	NN	B-NP
is	is	VBZ	0
about	about	RB	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
mi.	mi.	CD	I-NP
10	10	CD	0
.	.	.	0
The	The	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
6	6	CD	0
wherein	wherein	CD	0
the	the	DT	0
sodium	sodium	JJ	B-NP
azide	azide	NN	I-NP
is	is	VBZ	0
about	about	RB	0
0.08	0.08	CD	0
%	%	NN	0
wt.	wt.	CD	B-NP
/	/	CD	0
vol.	vol.	CD	B-NP
11	11	CD	0
.	.	.	0
A	A	DT	0
stabilizing	stabilizing	VBG	B-NP
biomolecule	biomolecule	NN	I-NP
diluent	diluent	NN	I-NP
in	in	IN	0
aqueous	aqueous	JJ	B-NP
solution	solution	NN	I-NP
,	,	,	0
comprising	comprising	VBG	0
50	50	CD	0
mmol	mmol	JJ	B-NP
tri	tri	NNP	I-NP
,	,	,	0
100	100	CD	0
mmol	mmol	JJ	B-NP
mannitol	mannitol	NN	I-NP
,	,	,	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
casein	casein	NN	I-NP
and	and	CC	0
sodium	sodium	CD	B-NP
azide	azide	CD	I-NP
0.08	0.08	CD	0
%	%	NN	0
.	.	.	0
12	12	CD	0
.	.	.	0
A	A	DT	0
method	method	NN	0
for	for	IN	0
stabilizing	stabilizing	VBG	0
a	a	DT	0
biomolecule	biomolecule	JJ	0
comprising	comprising	NNS	0
storing	storing	VBG	0
a	a	DT	0
biomolecule	biomolecule	NN	B-NP
in	in	IN	0
the	the	DT	0
diluent	diluent	NN	B-NP
of	of	IN	0
claim	claim	NN	0
1	1	CD	0
.	.	.	0
